0000021665 12/31 2021 Q3 false 0000021665 2021-01-01 2021-09-30 0000021665 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000021665 cl:A0.500NotesDue2026Member 2021-01-01 2021-09-30 0000021665 cl:A1.375NotesDue2034Member 2021-01-01 2021-09-30 0000021665 cl:A0.875Notesdue2039Member 2021-01-01 2021-09-30 xbrli:shares 0000021665 2021-09-30 iso4217:USD 0000021665 2021-07-01 2021-09-30 0000021665 2020-07-01 2020-09-30 0000021665 2020-01-01 2020-09-30 iso4217:USD xbrli:shares 0000021665 2020-12-31 0000021665 2019-12-31 0000021665 2020-09-30 0000021665 us-gaap:CommonStockMember 2021-06-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000021665 cl:UnearnedCompensationMember 2021-06-30 0000021665 us-gaap:TreasuryStockMember 2021-06-30 0000021665 us-gaap:RetainedEarningsMember 2021-06-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000021665 us-gaap:NoncontrollingInterestMember 2021-06-30 0000021665 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000021665 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000021665 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0000021665 us-gaap:CommonStockMember 2021-09-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000021665 cl:UnearnedCompensationMember 2021-09-30 0000021665 us-gaap:TreasuryStockMember 2021-09-30 0000021665 us-gaap:RetainedEarningsMember 2021-09-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000021665 us-gaap:NoncontrollingInterestMember 2021-09-30 0000021665 us-gaap:CommonStockMember 2020-06-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000021665 cl:UnearnedCompensationMember 2020-06-30 0000021665 us-gaap:TreasuryStockMember 2020-06-30 0000021665 us-gaap:RetainedEarningsMember 2020-06-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000021665 us-gaap:NoncontrollingInterestMember 2020-06-30 0000021665 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000021665 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000021665 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000021665 cl:UnearnedCompensationMember 2020-07-01 2020-09-30 0000021665 us-gaap:CommonStockMember 2020-09-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000021665 cl:UnearnedCompensationMember 2020-09-30 0000021665 us-gaap:TreasuryStockMember 2020-09-30 0000021665 us-gaap:RetainedEarningsMember 2020-09-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000021665 us-gaap:NoncontrollingInterestMember 2020-09-30 0000021665 2021-06-30 0000021665 2020-06-30 0000021665 us-gaap:CommonStockMember 2020-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000021665 cl:UnearnedCompensationMember 2020-12-31 0000021665 us-gaap:TreasuryStockMember 2020-12-31 0000021665 us-gaap:RetainedEarningsMember 2020-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2020-12-31 0000021665 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0000021665 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-09-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0000021665 us-gaap:TreasuryStockMember 2021-01-01 2021-09-30 0000021665 cl:UnearnedCompensationMember 2021-01-01 2021-09-30 0000021665 us-gaap:CommonStockMember 2019-12-31 0000021665 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000021665 cl:UnearnedCompensationMember 2019-12-31 0000021665 us-gaap:TreasuryStockMember 2019-12-31 0000021665 us-gaap:RetainedEarningsMember 2019-12-31 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000021665 us-gaap:NoncontrollingInterestMember 2019-12-31 0000021665 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0000021665 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-09-30 0000021665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000021665 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0000021665 us-gaap:TreasuryStockMember 2020-01-01 2020-09-30 0000021665 cl:UnearnedCompensationMember 2020-01-01 2020-09-30 cl:Dividend 0000021665 2021-01-01 2021-03-31 0000021665 2020-01-01 2020-03-31 0000021665 cl:HelloProductLLCMember 2020-01-31 2020-01-31 0000021665 cl:HelloProductLLCMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:TrademarksMember 2020-01-31 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 0000021665 cl:HelloProductLLCMember us-gaap:CustomerRelationshipsMember 2020-01-31 2020-01-31 0000021665 cl:HelloProductLLCMember srt:NorthAmericaMember 2020-01-31 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-07-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember cl:GlobalGrowthandEfficiencyProgramMember 2020-07-01 2020-09-30 0000021665 cl:GlobalGrowthandEfficiencyProgramMember cl:OtherIncomeExpenseNetMember 2020-07-01 2020-09-30 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2021-01-01 2021-09-30 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-01-01 2020-09-30 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2021-09-30 0000021665 cl:GlobalGrowthandEfficiencyProgramMember 2020-12-31 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-07-01 2021-09-30 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-07-01 2020-09-30 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0000021665 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0000021665 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-09-30 0000021665 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-09-30 0000021665 us-gaap:PensionPlansDefinedBenefitMember country:US 2021-07-01 2021-09-30 0000021665 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-07-01 2020-09-30 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000021665 us-gaap:PensionPlansDefinedBenefitMember country:US 2021-01-01 2021-09-30 0000021665 us-gaap:PensionPlansDefinedBenefitMember country:US 2020-01-01 2020-09-30 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000021665 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000021665 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000021665 2020-03-31 cl:country_and_territory 0000021665 srt:MinimumMember 2021-09-30 0000021665 srt:MaximumMember 2021-09-30 cl:case 0000021665 2005-12-31 0000021665 2017-07-31 0000021665 2019-04-30 cl:segment 0000021665 srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000021665 srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000021665 srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000021665 srt:NorthAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0000021665 srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000021665 srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000021665 srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000021665 srt:LatinAmericaMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0000021665 srt:EuropeMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000021665 srt:EuropeMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000021665 srt:EuropeMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000021665 srt:EuropeMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0000021665 srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000021665 srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000021665 srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000021665 srt:AsiaPacificMember cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember 2021-07-01 2021-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember 2020-07-01 2020-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember 2021-01-01 2021-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember cl:AfricaEurasiaMember 2020-01-01 2020-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000021665 cl:OralPersonalAndHomeCareMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0000021665 cl:PetNutritionMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000021665 cl:PetNutritionMember us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000021665 cl:PetNutritionMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000021665 cl:PetNutritionMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 xbrli:pure 0000021665 us-gaap:SalesRevenueNetMember 2021-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:OralCareMember us-gaap:ProductConcentrationRiskMember 2021-07-01 2021-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:OralCareMember us-gaap:ProductConcentrationRiskMember 2020-07-01 2020-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:OralCareMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:OralCareMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-09-30 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-07-01 2021-09-30 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-07-01 2020-09-30 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-09-30 0000021665 cl:PersonalCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-09-30 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-07-01 2021-09-30 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-07-01 2020-09-30 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-09-30 0000021665 cl:HomeCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:PetNutritionMember us-gaap:ProductConcentrationRiskMember 2021-07-01 2021-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:PetNutritionMember us-gaap:ProductConcentrationRiskMember 2020-07-01 2020-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:PetNutritionMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-09-30 0000021665 us-gaap:SalesRevenueNetMember cl:PetNutritionMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-09-30 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-07-01 2021-09-30 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-07-01 2020-09-30 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-09-30 0000021665 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-09-30 0000021665 us-gaap:CorporateNonSegmentMember 2021-07-01 2021-09-30 0000021665 us-gaap:CorporateNonSegmentMember 2020-07-01 2020-09-30 0000021665 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-09-30 0000021665 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-09-30 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember 2021-01-01 2021-09-30 0000021665 us-gaap:CorporateNonSegmentMember country:BR us-gaap:OperatingIncomeLossMember 2021-07-01 2021-09-30 0000021665 us-gaap:CorporateNonSegmentMember us-gaap:OperatingIncomeLossMember 2020-01-01 2020-09-30 0000021665 us-gaap:InterestRateContractMember us-gaap:OtherAssetsMember 2021-09-30 0000021665 us-gaap:InterestRateContractMember us-gaap:OtherAssetsMember 2020-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2021-09-30 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:OtherAssetsMember 2021-09-30 0000021665 us-gaap:ForwardContractsMember us-gaap:OtherAssetsMember 2020-12-31 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForwardContractsMember 2021-09-30 0000021665 us-gaap:OtherLiabilitiesMember us-gaap:ForwardContractsMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentLiabilitiesMember 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentLiabilitiesMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2021-09-30 0000021665 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2021-09-30 0000021665 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:OtherCurrentAssetsMember 2021-09-30 0000021665 us-gaap:OtherCurrentAssetsMember 2020-12-31 0000021665 us-gaap:FairValueInputsLevel2Member 2021-09-30 0000021665 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-09-30 0000021665 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0000021665 us-gaap:LongTermDebtMember 2021-09-30 0000021665 us-gaap:LongTermDebtMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2021-09-30 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2021-09-30 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2021-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:ForwardContractsMember 2021-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:CommodityContractMember 2021-09-30 0000021665 us-gaap:FairValueHedgingMember 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2021-09-30 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember us-gaap:ForwardContractsMember 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember us-gaap:CommodityContractMember 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-09-30 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2021-09-30 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-09-30 0000021665 us-gaap:ForwardContractsMember us-gaap:NetInvestmentHedgingMember 2021-09-30 0000021665 us-gaap:NetInvestmentHedgingMember us-gaap:CommodityContractMember 2021-09-30 0000021665 us-gaap:NetInvestmentHedgingMember 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:FairValueHedgingMember us-gaap:ForwardContractsMember 2020-12-31 0000021665 us-gaap:FairValueHedgingMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:FairValueHedgingMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:CashFlowHedgingMember us-gaap:InterestRateContractMember 2020-12-31 0000021665 us-gaap:CashFlowHedgingMember us-gaap:ForwardContractsMember 2020-12-31 0000021665 us-gaap:CashFlowHedgingMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:CashFlowHedgingMember 2020-12-31 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:DebtMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:ForwardContractsMember us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:NetInvestmentHedgingMember us-gaap:CommodityContractMember 2020-12-31 0000021665 us-gaap:NetInvestmentHedgingMember 2020-12-31 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2021-07-01 2021-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2021-07-01 2021-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2020-07-01 2020-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2020-07-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2021-07-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2021-07-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2020-07-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2020-07-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2021-07-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2021-07-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-07-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2020-07-01 2020-09-30 0000021665 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:CommodityContractMember 2021-07-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember us-gaap:CommodityContractMember 2021-07-01 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember us-gaap:CommodityContractMember 2021-07-01 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:CommodityContractMember 2020-07-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember us-gaap:CommodityContractMember 2020-07-01 2020-09-30 0000021665 us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember us-gaap:CommodityContractMember 2020-07-01 2020-09-30 0000021665 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-07-01 2021-09-30 0000021665 cl:InterestIncomeExpenseNetMember 2021-07-01 2021-09-30 0000021665 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2020-09-30 0000021665 cl:InterestIncomeExpenseNetMember 2020-07-01 2020-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2021-01-01 2021-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2021-01-01 2021-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2020-01-01 2020-09-30 0000021665 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2021-01-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2021-01-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember 2020-01-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2021-01-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember 2020-01-01 2020-09-30 0000021665 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:CommodityContractMember 2021-01-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember us-gaap:CommodityContractMember 2021-01-01 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember us-gaap:CommodityContractMember 2021-01-01 2021-09-30 0000021665 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:CommodityContractMember 2020-01-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember us-gaap:CommodityContractMember 2020-01-01 2020-09-30 0000021665 us-gaap:CashFlowHedgingMember cl:InterestIncomeExpenseNetMember us-gaap:CommodityContractMember 2020-01-01 2020-09-30 0000021665 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000021665 cl:InterestIncomeExpenseNetMember 2021-01-01 2021-09-30 0000021665 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0000021665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0000021665 cl:InterestIncomeExpenseNetMember 2020-01-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember 2020-07-01 2020-09-30 0000021665 us-gaap:ForwardContractsMember 2021-07-01 2021-09-30 0000021665 us-gaap:ForwardContractsMember 2020-07-01 2020-09-30 0000021665 us-gaap:CommodityContractMember 2021-07-01 2021-09-30 0000021665 us-gaap:CommodityContractMember 2020-07-01 2020-09-30 0000021665 us-gaap:DebtMember 2021-07-01 2021-09-30 0000021665 us-gaap:DebtMember 2020-07-01 2020-09-30 0000021665 us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0000021665 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-09-30 0000021665 us-gaap:ForwardContractsMember 2021-01-01 2021-09-30 0000021665 us-gaap:ForwardContractsMember 2020-01-01 2020-09-30 0000021665 us-gaap:CommodityContractMember 2021-01-01 2021-09-30 0000021665 us-gaap:CommodityContractMember 2020-01-01 2020-09-30 0000021665 us-gaap:DebtMember 2021-01-01 2021-09-30 0000021665 us-gaap:DebtMember 2020-01-01 2020-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
FORM 10-Q
_________________________
(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
| For the transition period from________ to________ .

Commission File Number: 1-644
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)

Delaware | 13-1815595
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)

| 300 Park Avenue |  |  |  |
| New York, | New York |  |  | 10022 |
(Address of principal executive offices) |  | (Zip Code) |

(212) 310-2000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, $1.00 par value |  | CL |  | New York Stock Exchange
0.500% Notes due 2026 |  | CL26 |  | New York Stock Exchange
1.375% Notes due 2034 |  | CL34 |  | New York Stock Exchange
0.875% Notes due 2039 |  | CL39 |  | New York Stock Exchange

NO CHANGES
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class |  | Shares Outstanding |  | Date
Common stock, $1.00 par value |  | 842,848,691 |  | September 30, 2021

PART I. FINANCIAL INFORMATION
COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Income
(Dollars in Millions Except Per Share Amounts)
(Unaudited)

| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Net sales | $ | 4,414 |  |  | $ | 4,153 |  |  | $ | 13,018 |  |  | $ | 12,147 |
Cost of sales | 1,791 |  |  | 1,613 |  |  | 5,202 |  |  | 4,773 |
Gross profit | 2,623 |  |  | 2,540 |  |  | 7,816 |  |  | 7,374 |
Selling, general and administrative expenses | 1,636 |  |  | 1,518 |  |  | 4,809 |  |  | 4,386 |
Other (income) expense, net | 20 |  |  | 4 |  |  | 40 |  |  | 72 |
Operating profit | 967 |  |  | 1,018 |  |  | 2,967 |  |  | 2,916 |
Non-service related postretirement costs | 16 |  |  | 15 |  |  | 52 |  |  | 56 |
Interest (income) expense, net | 98 |  |  | 36 |  |  | 152 |  |  | 107 |
Income before income taxes | 853 |  |  | 967 |  |  | 2,763 |  |  | 2,753 |
Provision for income taxes | 172 |  |  | 222 |  |  | 613 |  |  | 585 |
Net income including noncontrolling interests | 681 |  |  | 745 |  |  | 2,150 |  |  | 2,168 |
Less: Net income attributable to noncontrolling interests | 47 |  |  | 47 |  |  | 132 |  |  | 120 |
Net income attributable to Colgate-Palmolive Company | $ | 634 |  |  | $ | 698 |  |  | $ | 2,018 |  |  | $ | 2,048 |
Earnings per common share, basic | $ | 0.75 |  |  | $ | 0.81 |  |  | $ | 2.39 |  |  | $ | 2.39 |
Earnings per common share, diluted | $ | 0.75 |  |  | $ | 0.81 |  |  | $ | 2.38 |  |  | $ | 2.38 |

See Notes to Condensed Consolidated Financial Statements.
2

COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Comprehensive Income
(Dollars in Millions)
(Unaudited)

| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Net income including noncontrolling interests | $ | 681 |  |  | $ | 745 |  |  | $ | 2,150 |  |  | $ | 2,168 |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |
Cumulative translation adjustments | (116) |  |  | 57 |  |  | (168) |  |  | (230) |
Retirement plans and other retiree benefit adjustments | 31 |  |  | 54 |  |  | 49 |  |  | 84 |
Gains (losses) on cash flow hedges | 17 |  |  | 1 |  |  | 25 |  |  | (2) |
Total Other comprehensive income (loss), net of tax | (68) |  |  | 112 |  |  | (94) |  |  | (148) |
Total Comprehensive income including noncontrolling interests | 613 |  |  | 857 |  |  | 2,056 |  |  | 2,020 |
Less: Net income attributable to noncontrolling interests | 47 |  |  | 47 |  |  | 132 |  |  | 120 |
Less: Cumulative translation adjustments attributable to noncontrolling interests | (2) |  |  | 12 |  |  | (5) |  |  | (1) |
Total Comprehensive income attributable to noncontrolling interests | 45 |  |  | 59 |  |  | 127 |  |  | 119 |
Total Comprehensive income attributable to Colgate-Palmolive Company | $ | 568 |  |  | $ | 798 |  |  | $ | 1,929 |  |  | $ | 1,901 |

See Notes to Condensed Consolidated Financial Statements.
3

COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Balance Sheets
(Dollars in Millions)
(Unaudited)

| September 30, 2021 |  | December 31, 2020
Assets |  |  |
Current Assets |  |  |
Cash and cash equivalents | $ | 958 |  |  | $ | 888 |
Receivables (net of allowances of $80 and $89, respectively) | 1,424 |  |  | 1,264 |
Inventories | 1,670 |  |  | 1,673 |
Other current assets | 618 |  |  | 513 |
Total current assets | 4,670 |  |  | 4,338 |
Property, plant and equipment: |  |  |
Cost | 8,827 |  |  | 8,751 |
Less: Accumulated depreciation | (5,194) |  |  | (5,035) |
| 3,633 |  |  | 3,716 |
Goodwill | 3,685 |  |  | 3,824 |
Other intangible assets, net | 2,719 |  |  | 2,894 |
Deferred income taxes | 260 |  |  | 291 |
Other assets | 913 |  |  | 857 |
Total assets | $ | 15,880 |  |  | $ | 15,920 |
Liabilities and Shareholders’ Equity |  |  |
Current Liabilities |  |  |
Notes and loans payable | $ | 3 |  |  | $ | 258 |
Current portion of long-term debt | 11 |  |  | 9 |
Accounts payable | 1,258 |  |  | 1,393 |
Accrued income taxes | 452 |  |  | 403 |
Other accruals | 2,557 |  |  | 2,341 |
Total current liabilities | 4,281 |  |  | 4,404 |
Long-term debt | 7,682 |  |  | 7,334 |
Deferred income taxes | 399 |  |  | 426 |
Other liabilities | 2,491 |  |  | 2,655 |
Total liabilities | 14,853 |  |  | 14,819 |
Shareholders’ Equity |  |  |
Common stock | 1,466 |  |  | 1,466 |
Additional paid-in capital | 3,174 |  |  | 2,969 |
Retained earnings | 24,201 |  |  | 23,699 |
Accumulated other comprehensive income (loss) | (4,434) |  |  | (4,345) |
Unearned compensation | — |  |  | (1) |
Treasury stock, at cost | (23,816) |  |  | (23,045) |
Total Colgate-Palmolive Company shareholders’ equity | 591 |  |  | 743 |
Noncontrolling interests | 436 |  |  | 358 |
Total equity | 1,027 |  |  | 1,101 |
Total liabilities and equity | $ | 15,880 |  |  | $ | 15,920 |

See Notes to Condensed Consolidated Financial Statements.
4

COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Cash Flows
(Dollars in Millions)
(Unaudited)

| Nine Months Ended
| September 30,
| 2021 |  | 2020
Operating Activities |  |  |
Net income including noncontrolling interests | $ | 2,150 |  |  | $ | 2,168 |
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: |  |  |
Depreciation and amortization | 414 |  |  | 400 |
Restructuring and termination benefits, net of cash | (19) |  |  | (66) |
Stock-based compensation expense | 107 |  |  | 85 |
Loss on early extinguishment of debt | 75 |  |  | — |
Deferred income taxes | (146) |  |  | (124) |
Cash effects of changes in: |  |  |
Receivables | (198) |  |  | 62 |
Inventories | (37) |  |  | (214) |
Accounts payable and other accruals | (107) |  |  | 468 |
Other non-current assets and liabilities | (20) |  |  | (23) |
Net cash provided by (used in) operations | 2,219 |  |  | 2,756 |
Investing Activities |  |  |
Capital expenditures | (374) |  |  | (249) |
Purchases of marketable securities and investments | (118) |  |  | (109) |
Proceeds from sale of marketable securities and investments | 55 |  |  | 42 |
Payment for acquisitions, net of cash acquired | — |  |  | (352) |
Other investing activities | (25) |  |  | — |
Net cash provided by (used in) investing activities | (462) |  |  | (668) |
Financing Activities |  |  |
Short-term borrowing (repayment) less than 90 days, net | 205 |  |  | (796) |
Principal payments of debt | (118) |  |  | (7) |
Proceeds from issuance of debt | 119 |  |  | — |
Dividends paid | (1,183) |  |  | (1,162) |
Purchases of treasury shares | (964) |  |  | (578) |
Proceeds from exercise of stock options | 282 |  |  | 640 |
Purchase of non-controlling interest in subsidiaries | — |  |  | (99) |
Other financing activities | (9) |  |  | 34 |
Net cash provided by (used in) financing activities | (1,668) |  |  | (1,968) |
Effect of exchange rate changes on Cash and cash equivalents | (19) |  |  | (14) |
Net increase (decrease) in Cash and cash equivalents | 70 |  |  | 106 |
Cash and cash equivalents at beginning of the period | 888 |  |  | 883 |
Cash and cash equivalents at end of the period | $ | 958 |  |  | $ | 989 |
Supplemental Cash Flow Information |  |  |
Income taxes paid | $ | 742 |  |  | $ | 606 |

See Notes to Condensed Consolidated Financial Statements.
5

COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Changes in Shareholders’ Equity
(Dollars in Millions)
(Unaudited)

Three Months Ended September 30, 2021
| Colgate-Palmolive Company Shareholders’ Equity |  |
| Common Stock |  | Additional Paid-in Capital |  | Unearned Compensation |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss)(1) |  | Noncontrolling Interests
Balance, June 30, 2021 | $ | 1,466 |  |  | $ | 3,085 |  |  | $ | — |  |  | $ | (23,665) |  |  | $ | 23,946 |  |  | $ | (4,368) |  |  | $ | 398 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | 634 |  |  | — |  |  | 47 |
Other comprehensive income (loss), net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (66) |  |  | (2) |
Dividends ($0.45 per share) | — |  |  | — |  |  | — |  |  | — |  |  | (379) |  |  | — |  |  | (7) |
Stock-based compensation expense | — |  |  | 49 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Shares issued for stock options | — |  |  | 53 |  |  | — |  |  | 87 |  |  | — |  |  | — |  |  | — |
Shares issued for restricted stock units | — |  |  | (14) |  |  | — |  |  | 14 |  |  | — |  |  | — |  |  | — |
Treasury stock acquired | — |  |  | — |  |  | — |  |  | (251) |  |  | — |  |  | — |  |  | — |
Other | — |  |  | 1 |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | — |
Balance, September 30, 2021 | $ | 1,466 |  |  | $ | 3,174 |  |  | $ | — |  |  | $ | (23,816) |  |  | $ | 24,201 |  |  | $ | (4,434) |  |  | $ | 436 |

Three Months Ended September 30, 2020
| Colgate-Palmolive Company Shareholders’ Equity |  |
| Common Stock |  | Additional Paid-in Capital |  | Unearned Compensation |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss)(1) |  | Noncontrolling Interests
Balance June 30, 2020 | $ | 1,466 |  |  | $ | 2,666 |  |  | $ | (1) |  |  | $ | (22,075) |  |  | $ | 22,731 |  |  | $ | (4,519) |  |  | $ | 464 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | 698 |  |  | — |  |  | 47 |
Other comprehensive income (loss), net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 100 |  |  | 12 |
Dividends ($0.44 per share) | — |  |  | — |  |  | — |  |  | — |  |  | (379) |  |  | — |  |  | — |
Stock-based compensation expense | — |  |  | 53 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Shares issued for stock options | — |  |  | 130 |  |  | — |  |  | 132 |  |  | — |  |  | — |  |  | — |
Shares issued for restricted stock units | — |  |  | (13) |  |  | — |  |  | 13 |  |  | — |  |  | — |  |  | — |
Treasury stock acquired | — |  |  | — |  |  | — |  |  | (350) |  |  | — |  |  | — |  |  | — |
Noncontrolling interests assumed through acquisition | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (99) |
Other | — |  |  | 1 |  |  | — |  |  | — |  |  | 2 |  |  | (2) |  |  | (4) |
Balance, September 30, 2020 | $ | 1,466 |  |  | $ | 2,837 |  |  | $ | (1) |  |  | $ | (22,280) |  |  | $ | 23,052 |  |  | $ | (4,421) |  |  | $ | 420 |

(1) Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,321 at September 30, 2021 ($3,357 at September 30, 2020) and $3,207 at June 30, 2021 ($3,402 at June 30, 2020), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,129 at September 30, 2021 ($1,054 at September 30, 2020) and $1,160 at June 30, 2021 ($1,108 at June 30, 2020), respectively.
See Notes to Condensed Consolidated Financial Statements.
6

COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Changes in Shareholders’ Equity
(Dollars in Millions)
(Unaudited)

Nine Months Ended September 30, 2021
| Colgate-Palmolive Company Shareholders’ Equity |  |
| Common Stock |  | Additional Paid-in Capital |  | Unearned Compensation |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss)(1) |  | Noncontrolling Interests
Balance, December 31, 2020 | $ | 1,466 |  |  | $ | 2,969 |  |  | $ | (1) |  |  | $ | (23,045) |  |  | $ | 23,699 |  |  | $ | (4,345) |  |  | $ | 358 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | 2,018 |  |  | — |  |  | 132 |
Other comprehensive income (loss), net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (89) |  |  | (5) |
Dividends ($1.79 per share)* | — |  |  | — |  |  | — |  |  | — |  |  | (1,516) |  |  | — |  |  | (49) |
Stock-based compensation expense | — |  |  | 107 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Shares issued for stock options | — |  |  | 120 |  |  | — |  |  | 167 |  |  | — |  |  | — |  |  | — |
Shares issued for restricted stock units | — |  |  | (26) |  |  | — |  |  | 26 |  |  | — |  |  | — |  |  | — |
Treasury stock acquired | — |  |  | — |  |  | — |  |  | (964) |  |  | — |  |  | — |  |  | — |
Other | — |  |  | 4 |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |
Balance, September 30, 2021 | $ | 1,466 |  |  | $ | 3,174 |  |  | $ | — |  |  | $ | (23,816) |  |  | $ | 24,201 |  |  | $ | (4,434) |  |  | $ | 436 |

Nine Months Ended September 30, 2020
| Colgate-Palmolive Company Shareholders’ Equity |  |
| Common Stock |  | Additional Paid-in Capital |  | Unearned Compensation |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss)(1) |  | Noncontrolling Interests
Balance, December 31, 2019 | $ | 1,466 |  |  | $ | 2,488 |  |  | $ | (2) |  |  | $ | (22,063) |  |  | $ | 22,501 |  |  | $ | (4,273) |  |  | $ | 441 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | 2,048 |  |  | — |  |  | 120 |
Other comprehensive income (loss), net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (147) |  |  | (1) |
Dividends ($1.75 per share)* | — |  |  | — |  |  | — |  |  | — |  |  | (1,503) |  |  | — |  |  | (37) |
Stock-based compensation expense | — |  |  | 85 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Shares issued for stock options | — |  |  | 290 |  |  | — |  |  | 329 |  |  | — |  |  | — |  |  | — |
Shares issued for restricted stock units | — |  |  | (30) |  |  | — |  |  | 30 |  |  | — |  |  | — |  |  | — |
Treasury stock acquired | — |  |  | — |  |  | — |  |  | (578) |  |  | — |  |  | — |  |  | — |
Noncontrolling interests acquired | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (99) |
Other | — |  |  | 4 |  |  | 1 |  |  | 2 |  |  | 6 |  |  | (1) |  |  | (4) |
Balance, September 30, 2020 | $ | 1,466 |  |  | $ | 2,837 |  |  | $ | (1) |  |  | $ | (22,280) |  |  | $ | 23,052 |  |  | $ | (4,421) |  |  | $ | 420 |

(1) Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,321 at September 30, 2021 ($3,357 at September 30, 2020) and $3,158 at December 31, 2020 ($3,128 at December 31, 2019), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,129 at September 30, 2021 ($1,054 at September 30, 2020) and $1,178 at December 31, 2020 ($1,138 at December 31, 2019), respectively.
* Two dividends were declared in each of the first quarters of 2021 and 2020.
See Notes to Condensed Consolidated Financial Statements.
7

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
1. Basis of Presentation
The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.
For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission (the “SEC”).
2. Use of Estimates
Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.
3. Recent Accounting Pronouncements
In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying generally accepted accounting principles (“GAAP”) to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. In January 2021, the FASB issued ASU No. 2021-01, “Reference Rate Reform (Topic 848): Scope,” which clarified that certain optional expedients and exceptions in Topic 848 apply to derivatives that are affected by the discounting transition due to reference rate reform. These ASUs were effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The guidance has not had and is not expected to have a material impact on the Company’s Consolidated Financial Statements.
In October 2020, the FASB issued ASU No. 2020-10, “Codification Improvements.” This ASU improves the consistency of the codification topics by including all disclosure guidance in the appropriate disclosure section and also clarifies the application of various provisions in the codification. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.
In January 2020, the FASB issued ASU No. 2020-01, “Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)-Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” This ASU provides clarification of the interaction of rules for equity securities, the equity method of accounting and forward contracts and purchase options on certain types of securities. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.
In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance was effective for the Company beginning on January 1, 2021 and did not have a material impact on the Company’s Consolidated Financial Statements.
8

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
4. Acquisitions
Hello Products LLC (“hello”)
On January 31, 2020, the Company acquired hello, an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of the Company’s strategy to focus on high growth segments within its Oral Care, Personal Care and Pet Nutrition businesses.
The total purchase price consideration of $351 was allocated to the net assets acquired based on their respective estimated fair values as follows:

Receivables | $ | 11 |
Inventories | 13 |
Other assets and liabilities, net | (4) |
Other intangible assets | 160 |
Goodwill | 171 |
Fair value of net assets acquired | $ | 351 |

Other intangible assets acquired include trademarks, valued at $115, which are considered to have a finite useful life of 25 years, and customer relationships, valued at $45, which are considered to have a finite useful life of 17 years. Goodwill of $171 was allocated to the North America segment and is deductible for tax purposes.
Pro forma results of operations have not been presented as the impact on the Company’s Condensed Consolidated Financial Statements is not material.
9

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
5. Restructuring and Related Implementation Charges
The Company’s restructuring program (the “Global Growth and Efficiency Program”), which commenced in the fourth quarter of 2012, concluded on December 31, 2019. Initiatives under the Global Growth and Efficiency Program fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Substantially all initiatives under the Global Growth and Efficiency Program had been implemented as of December 31, 2019 and no new restructuring projects were approved for implementation subsequent to the conclusion of the Global Growth and Efficiency Program.
During the three months ended September 30, 2020, the Company adjusted the accrual balances related to certain projects approved prior to the conclusion of the Global Growth and Efficiency Program to reflect its revised estimate of remaining liabilities. This adjustment resulted in a reduction of $16 ($13 after-tax), of which $3 was recorded in Selling, general and administrative expenses and $13 was recorded in Other (income) expense, net.
During the nine months ended September 30, 2021 and September 30, 2020, the Company made cash payments of $19 and $50, respectively, related to projects approved prior to the conclusion of the Global Growth and Efficiency Program.
The accrual balance at September 30, 2021 and December 31, 2020 was $12 and $31, respectively.
6. Inventories
Inventories by major class were as follows:

| September 30, 2021 |  | December 31, 2020
Raw materials and supplies | $ | 451 |  |  | $ | 454 |
Work-in-process | 44 |  |  | 45 |
Finished goods | 1,261 |  |  | 1,256 |
Total Inventories, net | $ | 1,756 |  |  | $ | 1,755 |
Non-current inventory, net | $ | (86) |  |  | $ | (82) |
Current Inventories, net | $ | 1,670 |  |  | $ | 1,673 |

10

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
7. Earnings Per Share
For the three months ended September 30, 2021 and 2020, earnings per share were as follows:

| Three Months Ended
| September 30, 2021 |  | September 30, 2020
| Net income attributable to Colgate-Palmolive Company |  | Shares (millions) |  | Per Share |  | Net income attributable to Colgate-Palmolive Company |  | Shares (millions) |  | Per Share
Basic EPS | $ | 634 |  |  | 843.6 |  |  | $ | 0.75 |  |  | $ | 698 |  |  | 859.0 |  |  | $ | 0.81 |
Stock options and restricted stock units |  |  | 2.8 |  |  |  |  |  |  | 2.8 |  |  |
Diluted EPS | $ | 634 |  |  | 846.4 |  |  | $ | 0.75 |  |  | $ | 698 |  |  | 861.8 |  |  | $ | 0.81 |

For the three months ended September 30, 2021 and 2020, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 2,318,391 and 2,693,996, respectively.
For the nine months ended September 30, 2021 and 2020, earnings per share were as follows:

| Nine Months Ended
| September 30, 2021 |  | September 30, 2020
| Net income attributable to Colgate-Palmolive Company |  | Shares (millions) |  | Per Share |  | Net income attributable to Colgate-Palmolive Company |  | Shares (millions) |  | Per Share
Basic EPS | $ | 2,018 |  |  | 845.9 |  |  | $ | 2.39 |  |  | $ | 2,048 |  |  | 857.7 |  |  | $ | 2.39 |
Stock options and restricted stock units |  |  | 3.1 |  |  |  |  |  |  | 1.8 |  |  |
Diluted EPS | $ | 2,018 |  |  | 849.0 |  |  | $ | 2.38 |  |  | $ | 2,048 |  |  | 859.5 |  |  | $ | 2.38 |

For the nine months ended September 30, 2021 and 2020, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 2,763,779 and 15,862,643, respectively.
Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in the number of shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.
11

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
8. Other Comprehensive Income (Loss)
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended September 30, 2021 and 2020 were as follows:

|  | 2021 |  | 2020
|  | Pretax |  | Net of Tax |  | Pretax |  | Net of Tax
Cumulative translation adjustments |  | $ | (83) |  |  | $ | (114) |  |  | $ | 5 |  |  | $ | 45 |
Retirement plans and other retiree benefits: |  |  |  |  |  |  |  |
Net actuarial gain (loss) and prior service costs arising during the period |  | 23 |  |  | 17 |  |  | 53 |  |  | 41 |
Amortization of net actuarial loss, transition and prior service costs (1) |  | 18 |  |  | 14 |  |  | 15 |  |  | 13 |
Retirement plans and other retiree benefits adjustments |  | 41 |  |  | 31 |  |  | 68 |  |  | 54 |
Cash flow hedges: |  |  |  |  |  |  |  |
Unrealized gains (losses) on cash flow hedges |  | 18 |  |  | 15 |  |  | (1) |  |  | (1) |
Reclassification of (gains) losses into net earnings on cash flow hedges (2) |  | 2 |  |  | 2 |  |  | 2 |  |  | 2 |
Gains (losses) on cash flow hedges |  | 20 |  |  | 17 |  |  | 1 |  |  | 1 |
Total Other comprehensive income (loss) |  | $ | (22) |  |  | $ | (66) |  |  | $ | 74 |  |  | $ | 100 |

(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.
There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.
Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the nine months ended September 30, 2021 and 2020 were as follows:

|  | 2021 |  | 2020
|  | Pretax |  | Net of Tax |  | Pretax |  | Net of Tax
Cumulative translation adjustments |  | $ | (111) |  |  | $ | (163) |  |  | $ | (288) |  |  | $ | (229) |
Retirement plans and other retiree benefits: |  |  |  |  |  |  |  |
Net actuarial gain (loss) and prior service costs arising during the period |  | — |  |  | 2 |  |  | 55 |  |  | 42 |
Amortization of net actuarial loss, transition and prior service costs (1) |  | 61 |  |  | 47 |  |  | 55 |  |  | 42 |
Retirement plans and other retiree benefits adjustments |  | 61 |  |  | 49 |  |  | 110 |  |  | 84 |
Cash flow hedges: |  |  |  |  |  |  |  |
Unrealized gains (losses) on cash flow hedges |  | 22 |  |  | 17 |  |  | 2 |  |  | 1 |
Reclassification of (gains) losses into net earnings on cash flow hedges (2) |  | 9 |  |  | 8 |  |  | (4) |  |  | (3) |
Gains (losses) on cash flow hedges |  | 31 |  |  | 25 |  |  | (2) |  |  | (2) |
Total Other comprehensive income (loss) |  | $ | (19) |  |  | $ | (89) |  |  | $ | (180) |  |  | $ | (147) |

(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.
There were no tax impacts on OCI attributable to Noncontrolling interests.
12

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
9. Retirement Plans and Other Retiree Benefits
Components of Net periodic benefit cost for the three and nine months ended September 30, 2021 and 2020 were as follows:

| Three Months Ended September 30,
| Pension Benefits |  | Other Retiree Benefits
| United States |  | International |  |  |  |
| 2021 |  | 2020 |  | 2021 |  | 2020 |  | 2021 |  | 2020
Service cost | $ | — |  |  | $ | — |  |  | $ | 3 |  |  | $ | 4 |  |  | $ | 7 |  |  | $ | 3 |
Interest cost | 16 |  |  | 20 |  |  | 5 |  |  | 5 |  |  | 8 |  |  | 10 |
Expected return on plan assets | (27) |  |  | (29) |  |  | (4) |  |  | (6) |  |  | — |  |  | — |
Amortization of actuarial loss (gain) | 11 |  |  | 10 |  |  | 2 |  |  | 2 |  |  | 5 |  |  | 3 |
Net periodic benefit cost | $ | — |  |  | $ | 1 |  |  | $ | 6 |  |  | $ | 5 |  |  | $ | 20 |  |  | $ | 16 |

| Nine Months Ended September 30,
| Pension Benefits |  | Other Retiree Benefits
| United States |  | International |  |  |  |
| 2021 |  | 2020 |  | 2021 |  | 2020 |  | 2021 |  | 2020
Service cost | $ | 1 |  |  | $ | — |  |  | $ | 11 |  |  | $ | 11 |  |  | $ | 20 |  |  | $ | 14 |
Interest cost | 46 |  |  | 57 |  |  | 14 |  |  | 14 |  |  | 26 |  |  | 29 |
Expected return on plan assets | (81) |  |  | (83) |  |  | (14) |  |  | (15) |  |  | — |  |  | (1) |
Amortization of actuarial loss (gain) | 35 |  |  | 34 |  |  | 8 |  |  | 7 |  |  | 18 |  |  | 14 |
Net periodic benefit cost | $ | 1 |  |  | $ | 8 |  |  | $ | 19 |  |  | $ | 17 |  |  | $ | 64 |  |  | $ | 56 |

For the nine months ended September 30, 2021 and 2020, the Company made no voluntary contributions to its U.S. postretirement plans.
13

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
10. Income Taxes
The provision for income taxes for the nine months ended September 30, 2020 includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the Tax Cuts and Jobs Act (the “TCJA”).
As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes would be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, in the first quarter of 2020, reversed $45 of previously recorded foreign withholding taxes.
Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure implemented within one of the Company’s divisions, the Company believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, in the first quarter of 2020, reversed the previously recorded valuation allowance of $26.
11. Contingencies
As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.
The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.
The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $425 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.
Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.
14

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
Brazilian Matters
There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).
The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $109. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001.
In each of September 2015, February 2017, June 2018, April 2019 and September 2020, the Company lost an administrative appeal and subsequently filed an appeal in Brazilian federal court. Currently, there are five appeals pending in the Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.
In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $48, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.
15

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
Competition Matter
Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of September 30, 2021 of such competition law matters pending against the Company during the nine months ended September 30, 2021 is set forth below.
▪In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority have appealed the decision to the Greek Supreme Court.
Talcum Powder Matters
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of September 30, 2021, there were 168 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 151 cases as of June 30, 2021 and 137 cases as of December 31, 2020. During the three months ended September 30, 2021, 26 new cases were filed and nine cases were resolved by voluntary dismissal, settlement or dismissal by court. During the nine months ended September 30, 2021, 53 new cases were filed and 22 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The values of the settlements in the quarter and year-to-date period presented were not material, either individually or in the aggregate, to the Company’s results of operations in either such period.
A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes a portion of such costs will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions, policy limits and insurance carrier insolvencies.
While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters.
ERISA Matter
In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York (the “Court”). The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the Court granted in part and denied in part the Company Defendants’ motion for summary judgment and dismissed certain claims on consent of the parties. In August 2020, the Court granted the plaintiffs’ motion for summary judgment on the remaining claims. The Company and the Plan are contesting this action vigorously and, in September 2020, appealed to the United States Court of Appeals for the Second Circuit.
16

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
12. Segment Information
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition.
The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.
The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.
Net sales by segment were as follows:

| Three Months Ended | Nine Months Ended |  |
| September 30, | September 30, |  |
| 2021 |  | 2020 | 2021 |  | 2020 |  |  |  |
Net sales |  |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |  |
North America | $ | 931 |  |  | $ | 923 |  | $ | 2,765 |  |  | $ | 2,801 |  |  |  |  |
Latin America | 931 |  |  | 837 |  | 2,745 |  |  | 2,531 |  |  |  |  |
Europe | 718 |  |  | 712 |  | 2,144 |  |  | 2,004 |  |  |  |  |
Asia Pacific | 731 |  |  | 722 |  | 2,142 |  |  | 1,980 |  |  |  |  |
Africa/Eurasia | 258 |  |  | 255 |  | 796 |  |  | 736 |  |  |  |  |
Total Oral, Personal and Home Care | 3,569 |  |  | 3,449 |  | 10,592 |  |  | 10,052 |  |  |  |  |
Pet Nutrition | 845 |  |  | 704 |  | 2,426 |  |  | 2,095 |  |  |  |  |
Total Net sales | $ | 4,414 |  |  | $ | 4,153 |  | $ | 13,018 |  |  | $ | 12,147 |  |  |  |  |

Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
17

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:

| Three Months Ended | Nine Months Ended |  |
| September 30, | September 30, |  |
| 2021 |  | 2020 | 2021 |  | 2020 |  |  |  |
Net sales |  |  |  |  |  |  |  |  |  |
Oral Care | 44 | % |  | 44 | % | 44 | % |  | 43 | % |  |  |  |
Personal Care | 20 | % |  | 21 | % | 20 | % |  | 21 | % |  |  |  |
Home Care | 18 | % |  | 18 | % | 17 | % |  | 19 | % |  |  |  |
Pet Nutrition | 18 | % |  | 17 | % | 19 | % |  | 17 | % |  |  |  |
Total Net sales | 100 | % |  | 100 | % | 100 | % |  | 100 | % |  |  |  |

Operating profit by segment was as follows:

| Three Months Ended | Nine Months Ended |  |
| September 30, | September 30, |  |
| 2021 |  | 2020 | 2021 |  | 2020 |  |  |  |
Operating profit |  |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |  |
North America | $ | 183 |  |  | $ | 242 |  | $ | 585 |  |  | $ | 753 |  |  |  |  |
Latin America | 248 |  |  | 250 |  | 774 |  |  | 728 |  |  |  |  |
Europe | 178 |  |  | 169 |  | 524 |  |  | 482 |  |  |  |  |
Asia Pacific | 215 |  |  | 222 |  | 639 |  |  | 559 |  |  |  |  |
Africa/Eurasia | 44 |  |  | 61 |  | 153 |  |  | 174 |  |  |  |  |
Total Oral, Personal and Home Care | 868 |  |  | 944 |  | 2,675 |  |  | 2,696 |  |  |  |  |
Pet Nutrition | 233 |  |  | 196 |  | 661 |  |  | 588 |  |  |  |  |
Corporate | (134) |  |  | (122) |  | (369) |  |  | (368) |  |  |  |  |
Total Operating profit | $ | 967 |  |  | $ | 1,018 |  | $ | 2,967 |  |  | $ | 2,916 |  |  |  |  |

Corporate Operating profit (loss) for the nine months ended September 30, 2021 included a benefit related to a value-added tax matter in Brazil of $26. Corporate Operating profit (loss) for the nine months ended September 30, 2020 included charges for acquisition-related costs of $6.
18

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
13. Fair Value Measurements and Financial Instruments
The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.
The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.
The Company’s derivative instruments include interest rate swap contracts, forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.
The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at September 30, 2021 and December 31, 2020:

| Assets |  | Liabilities
| Account |  | Fair Value |  | Account |  | Fair Value
Designated derivative instruments |  | September 30, 2021 |  | December 31, 2020 |  |  |  | September 30, 2021 |  | December 31, 2020
Interest rate swap contracts | Other assets |  | $ | 8 |  |  | $ | 14 |  |  | Other liabilities |  | $ | — |  |  | $ | — |
Forward-starting interest rate swaps | Other assets |  | 24 |  |  | 5 |  |  | Other liabilities |  | 9 |  |  | — |
Foreign currency contracts | Other current assets |  | 22 |  |  | 7 |  |  | Other accruals |  | 37 |  |  | 93 |
Commodity contracts | Other current assets |  | — |  |  | 3 |  |  | Other accruals |  | — |  |  | — |
Total designated |  | $ | 54 |  |  | $ | 29 |  |  |  |  | $ | 46 |  |  | $ | 93 |
Other financial instruments |  |  |  |  |  |  |  |  |  |
Marketable securities | Other current assets |  | $ | 100 |  |  | $ | 37 |  |  |  |  |  |  |
Total other financial instruments |  | $ | 100 |  |  | $ | 37 |  |  |  |  |  |  |

19

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of September 30, 2021 and December 31, 2020. The estimated fair value of the Company’s long-term debt, including the current portion, as of September 30, 2021 and December 31, 2020, was $8,173 and $8,175, respectively, and the related carrying value was $7,693 and $7,343, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).
The following amounts were recorded on the Condensed Consolidated Balance Sheet related to the cumulative basis adjustment for fair value hedges as of:

| September 30, 2021 |  | December 31, 2020
Long-term debt: |  |  |
Carrying amount of hedged item | $ | 407 |  |  | $ | 413 |
Cumulative hedging adjustment included in the carrying amount | 8 |  |  | 14 |

The following tables present the notional values as of:

| September 30, 2021
| Foreign Currency Contracts |  | Foreign Currency Debt |  | Interest Rate Swaps |  | Forward-Starting Interest Rate Swaps |  | Commodity Contracts |  | Total
Fair Value Hedges | $ | 600 |  |  | $ | — |  |  | $ | 400 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,000 |
Cash Flow Hedges | 778 |  |  | — |  |  | — |  |  | 700 |  |  | 18 |  |  | 1,496 |
Net Investment Hedges | 692 |  |  | 4,403 |  |  | — |  |  | — |  |  | — |  |  | 5,095 |

| December 31, 2020
| Foreign Currency Contracts |  | Foreign Currency Debt |  | Interest Rate Swaps |  | Forward-Starting Interest Rate Swaps |  | Commodity Contracts |  | Total
Fair Value Hedges | $ | 589 |  |  | $ | — |  |  | $ | 400 |  |  | $ | — |  |  | $ | — |  |  | $ | 989 |
Cash Flow Hedges | 854 |  |  | — |  |  | — |  |  | 300 |  |  | 17 |  |  | 1,171 |
Net Investment Hedges | 528 |  |  | 4,523 |  |  | — |  |  | — |  |  | — |  |  | 5,051 |

20

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
The following tables present the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:

| Three Months Ended September 30,
| 2021 |  | 2020
| Cost of sales |  | Selling, general and administrative expenses |  | Interest (income) expense, net |  | Cost of sales |  | Selling, general and administrative expenses |  | Interest (income) expense, net
Interest rate swaps designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  |
Derivative instrument | $ | — |  |  | $ | — |  |  | $ | 2 |  |  | $ | — |  |  | $ | — |  |  | $ | 2 |
Hedged items | — |  |  | — |  |  | (2) |  |  | — |  |  | — |  |  | (2) |
Foreign currency contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  |
Derivative instrument | — |  |  | 1 |  |  | — |  |  | — |  |  | (10) |  |  | — |
Hedged items | — |  |  | (1) |  |  | — |  |  | — |  |  | 10 |  |  | — |
Foreign currency contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  |
Amount reclassified from OCI | (2) |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | — |
Commodity contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  |
Amount reclassified from OCI | — |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | — |
Total gain (loss) on hedges recognized in income | $ | (2) |  |  | $ | — |  |  | $ | — |  |  | $ | (2) |  |  | $ | — |  |  | $ | — |

| Nine Months ended September 30,
| 2021 |  | 2020
| Cost of sales |  | Selling, general and administrative expenses |  | Interest (income) expense, net |  | Cost of sales |  | Selling, general and administrative expenses |  | Interest (income) expense, net
Interest rate swaps designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  |
Derivative instrument | $ | — |  |  | $ | — |  |  | $ | 6 |  |  | $ | — |  |  | $ | — |  |  | $ | (11) |
Hedged items | — |  |  | — |  |  | (6) |  |  | — |  |  | — |  |  | 11 |
Foreign currency contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  |
Derivative instrument | — |  |  | (4) |  |  | — |  |  | — |  |  | 29 |  |  | — |
Hedged items | — |  |  | 4 |  |  | — |  |  | — |  |  | (29) |  |  | — |
Foreign currency contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  |
Amount reclassified from OCI | (14) |  |  | — |  |  | — |  |  | 6 |  |  | — |  |  | — |
Commodity contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  |
Amount reclassified from OCI | 5 |  |  | — |  |  | — |  |  | (2) |  |  | — |  |  | — |
Total gain (loss) on hedges recognized in income | $ | (9) |  |  | $ | — |  |  | $ | — |  |  | $ | 4 |  |  | $ | — |  |  | $ | — |

21

COLGATE-PALMOLIVE COMPANY
Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)
The following table presents the location and amount of unrealized gains (losses) included in OCI:

| Three Months Ended
September 30,
2021 |  | 2020
Foreign currency contracts designated as cash flow hedges: |  |  |
Gain (loss) recognized in OCI | $ | 8 |  |  | $ | (7) |
Forward-starting interest rate swaps designated as cash flow hedges: |  |  |
Gain (loss) recognized in OCI | 12 |  |  | 4 |
Commodity contracts designated as cash flow hedges: |  |  |
Gain (loss) recognized in OCI | (2) |  |  | 2 |
Foreign currency contracts designated as net investment hedges: |  |  |
Gain (loss) on instruments | 19 |  |  | (21) |
Gain (loss) on hedged items | (19) |  |  | 21 |
Foreign currency debt designated as net investment hedges: |  |  |
Gain (loss) on instruments | 112 |  |  | (171) |
Gain (loss) on hedged items | (112) |  |  | 171 |
Total unrealized gain (loss) on hedges recognized in OCI | $ | 18 |  |  | $ | (1) |

| Nine Months Ended
September 30,
2021 |  | 2020
Foreign currency contracts designated as cash flow hedges: |  |  |
Gain (loss) recognized in OCI | $ | 12 |  |  | $ | 6 |
Forward-starting interest rate swaps designated as cash flow hedges: |  |  |
Gain (loss) recognized in OCI | 10 |  |  | (4) |
Commodity contracts designated as cash flow hedges: |  |  |
Gain (loss) recognized in OCI | — |  |  | — |
Foreign currency contracts designated as net investment hedges: |  |  |
Gain (loss) on instruments | 23 |  |  | (8) |
Gain (loss) on hedged items | (23) |  |  | 8 |
Foreign currency debt designated as net investment hedges: |  |  |
Gain (loss) on instruments | 261 |  |  | (174) |
Gain (loss) on hedged items | (261) |  |  | 174 |
Total unrealized gain (loss) on hedges recognized in OCI | $ | 22 |  |  | $ | 2 |

22

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Executive Overview
Business Organization
Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate”) is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. We seek to deliver sustainable, profitable growth and superior shareholder returns, as well as to provide Colgate people with an innovative and inclusive work environment. We do this by developing and selling products globally that make people’s lives and their pets healthier and more enjoyable and by embracing our sustainability and social impact and diversity, equity and inclusion strategies across our organization.
We are tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, we follow a closely defined business strategy to grow our key product categories and increase our overall market share. Within the categories in which we compete, we prioritize our efforts based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable, profitable long-term growth.
Operationally, we are organized along geographic lines with management teams having responsibility for the business and financial results in each region. We compete in more than 200 countries and territories worldwide with established businesses in all regions contributing to our sales and profitability. Approximately 70% of our Net sales are generated from markets outside the U.S., with approximately 45% of our Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce our exposure to business and other risks in any one country or part of the world.
The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors. Through Hill’s Pet Nutrition, we also compete on a worldwide basis in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians and eCommerce retailers. We are engaged in manufacturing and sourcing of products and materials on a global scale and have major manufacturing facilities, warehousing facilities and distribution centers in every region around the world.
On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case, on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. In addition, we review market share data to assess how our brands are performing within their categories on a global and regional basis. The monitoring of these indicators and our Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures and the Company’s use of market share data and the limitations of such data, see “Non-GAAP Financial Measures” and “Market Share Information” below.
23

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
COVID-19
The COVID-19 pandemic and government steps to reduce the spread and address the impact of COVID-19 have had and continue to have a profound impact on the way people live, work, interact and shop and have significantly impacted and continue to impact economic activity around the world. We have a well-established Crisis Management Team (“CMT”) process, and the CMT, together with our senior management team and Colgate people around the world, continue to respond to and manage the challenges presented by COVID-19.
During the COVID-19 pandemic, many of the communities in which we manufacture, market and sell our products have experienced and in some cases continue to experience unprecedented “stay at home” orders, travel or movement restrictions and other government actions to reduce the spread and address the impact of COVID-19, and have implemented varying policies to address the pandemic, resume economic activity and vaccinate their populations. The situation continues to be uncertain and varies by geography, as the impact of COVID-19 remains significant in many countries throughout the world, including Brazil, China, India, Mexico, Thailand and Vietnam where we have substantial manufacturing facilities. Because the vast majority of our products (such as oral care products, soaps and other personal hygiene products, home cleaners and pet food) have been deemed essential for the health and well-being of people and their pets, we have, in most instances, been able to continue operating our business, although not always at full capacity.
The health, safety and well-being of our employees has been and remains our first priority. While many of our office-based employees globally continue to work from home, we have reopened our offices, in some instances on a limited and voluntary basis, where circumstances have enabled us to do so. In those circumstances, and in instances where employees cannot perform their work at home, such as in our factories and our laboratories, we have implemented additional health and safety measures consistent with government recommendations and/or requirements to help ensure employee safety, often at additional cost. These measures include: health screening, social distancing and personal protective equipment protocols, contact tracing, enhanced cleaning procedures and, in some instances, testing and vaccination requirements. In addition, during the COVID-19 pandemic, we have seen increased instances of absenteeism and, in some cases, we have experienced some limited factory closures. Furthermore, some of our suppliers, customers, distributors, logistics providers and service providers have experienced disruptions to their businesses.
We saw a significant increase in demand across many of our categories, such as liquid hand soap, dish liquid, bar soap and cleaners, during 2020 as a result of the COVID-19 pandemic, driven by consumer pantry-loading and increased consumption of our products. While during the nine months ended September 30, 2021, consumer demand for some of these categories declined year-over-year, it remained above historical levels, and we believe that some of this increase in consumption is sustainable in light of changes in consumer behavior related to COVID-19. Across our business, changes in consumer demand for our products vary by product category and geography depending on, among other things, the severity of the COVID-19 outbreak and retailer availability. At the same time, during the COVID-19 pandemic, we have experienced disruptions in certain channels, including travel retail. We also continue to see changes in the purchasing patterns of our consumers, including the nature and/or frequency of visits by consumers to retailers and dental, veterinary and skin health professionals and a shift in many markets to purchasing our products online.
COVID-19 and government steps to reduce the spread and address the impact of COVID-19 have impacted and may continue to impact our consumers’ ability to purchase and our ability to manufacture and distribute our products. While we believe that, in the long-term, consumer demand for the products in our categories will continue to be strong, uncertainties continue surrounding the timing and extent of the pandemic and the recovery from it. These uncertainties include: the impact of the timing and scale of changes to travel and movement restrictions in certain geographies, the availability and widespread distribution and use of safe and effective COVID-19 vaccines, the emergence and spread of COVID-19 variants such as the Delta variant, the timing and impact of consumer pantry-loading and destocking activity in certain markets, product demand trends and the impact of COVID-19 on the global economy. COVID-19 has also disrupted our retail customers, contract manufacturers, logistics providers and other third parties; their ability to address COVID-19 and maintain their operations at full capacity has impacted and may continue to impact sales of and consumer access to our products. We expect the ongoing economic impact and health concerns associated with COVID-19 to continue to impact consumer behavior, shopping patterns and consumption preferences once government restrictions are lifted and economies around the world reopen.
24

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
While we currently expect to be able to continue operating our business as described above and we intend to continue to work with government authorities and to follow the necessary protocols to maintain the health and safety of our employees and contract providers, uncertainty resulting from COVID-19 could result in an unforeseen additional disruption to our business, including our global supply chain and retailer network, and/or require us to incur additional operational costs.
For more information about the anticipated COVID-19 impact, see “Outlook” below.
25

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Business Strategy
To achieve our business and financial objectives, we are focused on innovating our core businesses; improving our brand building activities with an elevated brand purpose model and the use of equity advertising; innovating to gain market share in high growth segments and adjacencies; expanding into new channels and markets; maximizing growth online; and investing to drive consumption in growing populations. We continue to develop initiatives to build strong relationships with consumers, dental, veterinary and skin health professionals and traditional and eCommerce retailers. In addition, we continue to invest behind our brands, not just in terms of advertising, but also to build key growth capabilities in areas such as innovation and data and analytics. We also continue to broaden our eCommerce offerings, including direct-to-consumer and subscription services. We continue to believe that growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for our products. We are also working to integrate our sustainability and social impact and diversity, equity and inclusion strategies across our organization.
In addition, we are changing the way we work to drive growth and how we approach innovation to respond to the dynamic retail landscape and the evolving preferences of our customers and consumers. The retail landscape, the ease of new entrants into the market in many of our categories and the evolving preferences of our customers and consumers demand that we work differently and faster in an agile, authentic and culturally relevant manner to drive innovation.
The investments needed to drive growth are supported by strong cash flow performance and our disciplined capital allocation strategy. These investments are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as our funding-the-growth initiatives, we seek to become even more effective and efficient throughout our businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. We also continue to prioritize our investments in high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses, including by expanding our portfolio in premium skin health.
Significant Items Impacting Comparability
In 1990, the Company’s Canadian subsidiary (“CP Canada”), issued C$145 of Canadian dollar-denominated unsecured unsubordinated 12.85% guaranteed notes due October 4, 2030 (the “Canada notes”). On August 26, 2021, CP Canada redeemed the Canada notes and recorded a loss on the early extinguishment of debt of $75 pretax ($55 aftertax), which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished.
In 2019, we received a favorable judgment regarding certain value-added tax previously paid in Brazil. As a result of this favorable judgment, during the fourth quarter of 2019, we filed an application with the Brazilian government to recover value-added tax previously paid and recorded a benefit. In May 2021, the Brazilian Supreme Court issued a clarifying ruling allowing a higher deduction of state value-added tax when determining the taxable base. In light of this ruling, we recorded an additional benefit of $26 pretax ($20 aftertax) in the nine months ended September 30, 2021.
The provision for income taxes for the nine months ended September 30, 2020 includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described in “Results of Operations-Income Taxes,” and in Note 10, Income Taxes to the Condensed Consolidated Financial Statements, both items were previously recorded in connection with the charge recorded in 2017 and revised in 2018 related to the Tax Cuts and Jobs Act (the “TCJA”).
On January 31, 2020, we acquired Hello Products LLC (“hello”), an oral care business, for cash consideration of $351. The acquisition was financed with a combination of debt and cash. This acquisition is part of our strategy to focus on high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses. See Note 4, Acquisitions to the Condensed Consolidated Financial Statements for additional information.
26

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Outlook
Looking forward, we expect global macroeconomic, political and market conditions to remain challenging, especially due to COVID-19. During the three months ended September 30, 2021, all of our divisions experienced significantly higher raw and packaging material costs. We also incurred increased logistics costs due to volume and capacity constraints in the shipping and logistics industry and higher eCommerce demand. We expect this difficult cost environment to continue for at least the remainder of the year.
While the global marketplace in which we operate has always been highly competitive, we continue to experience heightened competitive activity in certain markets from strong local competitors, from other large multinational companies, some of which have greater resources than we do, and from new entrants into the market in many of our categories. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. We have seen increases in promotional activities in certain markets as retailers try aggressively to get consumers back into the stores as “stay at home” and other government restrictions continue to ease, a trend we expect will continue.
We have been negatively affected by changes in the policies and practices of our trade customers in key markets, such as inventory de-stocking, limitations on access to shelf space, delisting of our products and certain sustainability, supply chain and packaging initiatives. In addition, the retail landscape in many of our markets continues to evolve as a result of the rapid growth of eCommerce, changing consumer preferences (as consumers increasingly shop online) and the increased presence of alternative retail channels, such as subscription services and direct-to-consumer businesses. These trends have been magnified due to COVID-19 in many of our geographies and we plan to continue to invest behind our eCommerce capabilities. This rapid growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers.
In addition, given that approximately 70% of our Net sales originate in markets outside the U.S., we have experienced and will likely continue to experience volatile foreign currency fluctuations. As discussed above, we have also experienced higher raw and packaging material and logistics costs. While we have taken, and will continue to take, measures to mitigate the effect of these conditions, such as our funding the growth and revenue growth management initiatives, including additional pricing, in the current environment, it may become increasingly difficult to implement certain of these mitigation strategies. Should these conditions persist, they could adversely affect our future results.
As discussed above, we continue to closely monitor the impact of COVID-19 on our business. During the first year of the COVID-19 pandemic, we saw improvement in category growth rates due to heightened demand for certain health and hygiene products, particularly liquid hand soap, dish liquid, bar soap and cleaners. We believe some of this increased consumption is sustainable due to consumer behavior changes related to COVID-19. However, we expect increased volatility across all of our categories and it is therefore difficult to predict category growth rates in the near term. COVID-19 has also disrupted our retail customers, contract manufacturers, logistics providers and other third parties; their ability to address COVID-19 and maintain their operations at full capacity has impacted and may continue to impact sales of and consumer access to our products. While we have taken, and will continue to take, measures to mitigate the effects of COVID-19, we cannot estimate with certainty the full extent of COVID-19’s impact on our business, results of operations, cash flows and/or financial condition. For more information about factors that could impact our business, including due to COVID-19, see “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020.
In summary, we believe that we are well prepared to meet the challenges ahead due to our strong financial condition, broad based experience operating in challenging environments, resilient global supply chain and focused business strategy. Our strategy is based on driving organic sales growth through innovation within our core businesses, leveraging faster growth in adjacent categories and expanding in high-growth channels and markets; delivering margin expansion through operating leverage and efficiency; and maximizing the impact of our environmental, social and governance programs and leading in the development of human capital, including our sustainability and social impact and diversity, equity and inclusion strategies. Our commitment to these priorities, the strength of our brands, the breadth of our global footprint and a commitment to driving efficiency in cash generation should position us well to manage through the challenges presented by COVID-19 and increase shareholder value over time.
27

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
28

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Results of Operations
Three Months
Worldwide Net sales were $4,414 in the third quarter of 2021, up 6.5% from the third quarter of 2020, due to volume growth of 1.5%, net selling price increases of 3.0% and positive foreign exchange of 2.0%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, increased 4.5% in the third quarter of 2021. A reconciliation of net sales growth to organic sales growth is provided under “Non-GAAP Financial Measures” below.
Net sales in the Oral, Personal and Home Care product segment were $3,569 in the third quarter of 2021, up 3.5% from the third quarter of 2020, due to net selling price increases of 1.5% and positive foreign exchange of 2.0%, while volume remained flat. Organic sales in the Oral, Personal and Home Care product segment increased 1.5% in the third quarter of 2021.
The Company’s share of the global toothpaste market was 39.5% on a year-to-date basis, down 0.4 share points from the year ago period, and its share of the global manual toothbrush market was 31.0% on a year-to-date basis, up 0.1 share points from the year ago period. Year-to-date market shares in toothpaste were up in Africa/Eurasia, down in North America, Latin America and Asia Pacific and flat in Europe, versus the comparable 2020 period. In the manual toothbrush category, year-to-date market shares were up in Latin America, Europe and Africa/Eurasia and down in North America and Asia Pacific versus the comparable 2020 period. For additional information regarding market shares, see “Market Share Information” below.
Net sales in the Hill’s Pet Nutrition segment were $845 in the third quarter of 2021, up 20.0% from the third quarter of 2020, due to volume growth of 11.0%, net selling price increases of 8.0% and positive foreign exchange of 1.0%. Organic sales in the Hill’s Pet Nutrition segment increased 19.0% in the third quarter of 2021.
29

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Gross Profit/Margin
Worldwide Gross profit increased to $2,623 in the third quarter of 2021 from $2,540 in the third quarter of 2020, reflecting an increase of $161 resulting from higher Net sales and a decrease of $78 resulting from lower Gross profit margin.
Worldwide Gross profit margin decreased to 59.4% in the third quarter of 2021 from 61.2% in the third quarter of 2020. This decrease in Gross profit margin was primarily due to significantly higher raw and packaging material costs (510 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (220 bps) and higher pricing (110 bps).

|  | Three Months Ended September 30,
|  | 2021 |  | 2020
Gross profit |  | $ | 2,623 |  |  | $ | 2,540 |

|  | Three Months Ended September 30,
|  | 2021 |  | 2020 |  | Basis Point Change
Gross profit margin |  | 59.4 | % |  | 61.2 | % |  | (180) |

30

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased 8% to $1,636 in the third quarter of 2021 from $1,518 in the third quarter of 2020. Selling, general and administrative expenses in the third quarter of 2020 included benefits resulting from the Global Growth and Efficiency Program. Excluding benefits resulting from the Global Growth and Efficiency Program in the third quarter of 2020, Selling, general, and administrative expenses, increased to $1,636 in the third quarter of 2021 from $1,521 in the third quarter of 2020, reflecting higher overhead expenses of $88 and increased advertising investment of $27.
Selling general, and administrative expenses as a percentage of Net Sales increased to 37.1% in the third quarter of 2021 from 36.6% in the third quarter of 2020. This increase was largely due to higher overhead expenses (60 bps), driven by higher logistics costs (150 bps) which impacted all divisions, partially offset by other overhead efficiencies. In the third quarter of 2021, advertising investment decreased as a percentage of Net sales to 11.4% from 11.5% in the third quarter of 2020, while it increased 6% in absolute terms to $503 as compared with $476 in the third quarter of 2020.

|  | Three Months Ended September 30,
|  | 2021 |  | 2020
Selling, general and administrative expenses, GAAP |  | $ | 1,636 |  |  | $ | 1,518 |
Global Growth and Efficiency Program |  | — |  |  | 3 |
Selling, general and administrative expenses, non-GAAP |  | $ | 1,636 |  |  | $ | 1,521 |

|  | Three Months Ended September 30,
|  | 2021 |  | 2020 |  | Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales |  | 37.1 | % |  | 36.6 | % |  | 50

31

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Operating Profit
Operating profit decreased 5% to $967 in the third quarter of 2021 from $1,018 in the third quarter of 2020. Operating profit in the third quarter of 2020 included benefits resulting from the Global Growth and Efficiency Program. Excluding benefits resulting from the Global Growth and Efficiency Program in the third quarter of 2020, Operating profit decreased 3% to $967 in the third quarter of 2021 from $1,002 in the third quarter of 2020.
Operating profit margin was 21.9% in the third quarter of 2021, a decrease of 260 bps compared to 24.5% in the third quarter of 2020. Excluding the benefits resulting from the Global Growth and Efficiency Program in the third quarter of 2020, Operating profit margin was 21.9% in the third quarter of 2021, a decrease of 220 bps compared to 24.1% in the third quarter of 2020. This decrease in Operating profit margin was primarily due to a decrease in Gross profit (180 bps) and an increase in Selling, general and administrative expenses (50 bps), both as a percentage of Net sales.

|  | Three Months Ended September 30,
|  | 2021 |  | 2020 |  | % Change
Operating profit, GAAP |  | $ | 967 |  |  | $ | 1,018 |  |  | (5) | %
Global Growth and Efficiency Program |  | — |  |  | (16) |  |  | — |
Operating profit, non-GAAP |  | $ | 967 |  |  | $ | 1,002 |  |  | (3) | %

|  | Three Months Ended September 30,
|  | 2021 |  | 2020 |  | Basis Point Change
Operating profit margin, GAAP |  | 21.9 | % |  | 24.5 | % |  | (260) |
Global Growth and Efficiency Program |  | — | % |  | (0.4) | % |  | — |
Operating profit margin, non-GAAP |  | 21.9 | % |  | 24.1 | % |  | (220) |

Non-Service Related Postretirement Costs
Non-service related postretirement costs were $16 in the third quarter of 2021 as compared to $15 in the third quarter of 2020.
Interest (Income) Expense, Net
Interest (income) expense, net was $98 in the third quarter of 2021 as compared to $36 in the third quarter of 2020. The increase in Interest (income) expense, net in the third quarter of 2021 as compared to the third quarter of 2020, was primarily due to the loss on the early extinguishment of debt during the third quarter of 2021 of $75, representing the difference between the redemption price of the Canada notes and the carrying amount of the debt extinguished. Excluding the loss on the early extinguishment of debt, Interest (income) expense, net was $23 in the third quarter of 2021 as compared to $36 in the third quarter of 2020, primarily due to lower average interest rates on debt.

|  | Three Months Ended September 30,
|  | 2021 |  | 2020
Interest (income) expense, net, GAAP |  | $ | 98 |  |  | $ | 36 |
Loss on early extinguishment of debt |  | (75) |  |  | — |
Interest (income) expense, net, non-GAAP |  | $ | 23 |  |  | $ | 36 |

32

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share
Net income attributable to Colgate-Palmolive Company in the third quarter of 2021 decreased to $634 from $698 in the third quarter of 2020, and Earnings per common share on a diluted basis decreased to $0.75 per share in the third quarter of 2021 from $0.81 in the third quarter of 2020. Net Income attributable to Colgate-Palmolive Company in the third quarter of 2021 included a loss on the early extinguishment of debt, and in the third quarter of 2020 included benefits resulting from the Global Growth and Efficiency Program.
Excluding the items described above in both periods as applicable, Net income attributable to Colgate-Palmolive Company in the third quarter of 2021 increased 1% to $689 from $685 in the third quarter of 2020, and Earnings per common share on a diluted basis increased 3% to $0.81 in the third quarter of 2021 from $0.79 in the third quarter of 2020.

| Three Months Ended September 30, 2021
| Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Net Income Including Noncontrolling Interests |  | Net Income Attributable To Colgate-Palmolive Company |  |  |  | Diluted Earnings Per Share(2)
As Reported GAAP | $ | 853 |  |  | $ | 172 |  |  | $ | 681 |  |  | $ | 634 |  |  |  |  | $ | 0.75 |
Loss on early extinguishment of debt | 75 |  |  | 20 |  |  | 55 |  |  | 55 |  |  |  |  | 0.06 |
Non-GAAP | $ | 928 |  |  | $ | 192 |  |  | $ | 736 |  |  | $ | 689 |  |  |  |  | $ | 0.81 |

| Three Months Ended September 30, 2020
| Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Net Income Including Noncontrolling Interests |  |  | Net Income Attributable To Colgate-Palmolive Company |  |  | Diluted Earnings Per Share(2)
As Reported GAAP | $ | 967 |  |  | $ | 222 |  |  | $ | 745 |  |  |  | $ | 698 |  |  |  | $ | 0.81 |
Global Growth and Efficiency Program | (16) |  |  | (3) |  |  | (13) |  |  |  | (13) |  |  |  | (0.02) |
Non-GAAP | $ | 951 |  |  | $ | 219 |  |  | $ | 732 |  |  |  | $ | 685 |  |  |  | $ | 0.79 |

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
33

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Net Sales and Operating Profit by Segment
Oral, Personal and Home Care
North America

| Three Months Ended September 30,
| 2021 |  | 2020 |  | Change
Net sales | $ | 931 |  |  | $ | 923 |  |  | 1.0 |  | %
Operating profit | $ | 183 |  |  | $ | 242 |  |  | (24) |  | %
% of Net sales | 19.7 | % |  | 26.2 | % |  | (650) |  | bps

Net sales in North America increased 1.0% in the third quarter of 2021 to $931 due to net selling price increases of 0.5% and positive foreign exchange of 0.5%, while volume remained flat. Organic sales in North America increased 0.5% in the third quarter of 2021.
The increase in organic sales in North America in the third quarter of 2021 versus the third quarter of 2020 was primarily due to an increase in Oral Care organic sales, partially offset by decreases in Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories, partially offset by organic sales declines in the prescription dental and power toothbrush categories. The decrease in Personal Care was primarily due to organic sales declines in the liquid hand soap, body wash and bar soap categories, partially offset by organic sales growth in the skin health category. The decrease in Home Care was primarily due to organic sales declines in the hand dish category, partially offset by organic sales growth in the liquid cleaners and fabric softener categories.
Operating profit in North America decreased 24% in the third quarter of 2021 to $183, or 650 bps to 19.7% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit (440 bps) and an increase in Selling, general and administrative expenses (360 bps), partially offset by a decrease in Other (income) expense, net (150 bps), all as a percentage of Net sales. This decrease in Gross profit was primarily due to significantly higher raw and packaging material costs (660 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (200 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (310 bps), driven by higher logistics costs, and increased advertising investment (50 bps). This decrease in Other (income) expense, net was primarily due to an inventory write off in the third quarter of 2020.
34

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Latin America

| Three Months Ended September 30,
| 2021 |  | 2020 |  | Change
Net sales | $ | 931 |  |  | $ | 837 |  |  | 11.0 |  | %
Operating profit | $ | 248 |  |  | $ | 250 |  |  | (1) |  | %
% of Net sales | 26.6 | % |  | 29.9 | % |  | (330) |  | bps

Net sales in Latin America increased 11.0% in the third quarter of 2021 to $931, due to volume growth of 2.5%, net selling price increases of 5.5% and positive foreign exchange of 3.0%. Organic sales in Latin America increased 8.0% in the third quarter of 2021. Organic sales growth was led by Mexico, Brazil, Colombia and Argentina.
The increase in organic sales in Latin America in the third quarter of 2021 versus the third quarter of 2020 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap category. The increase in Home Care was primarily due to organic sales growth in the liquid cleaner and fabric softener categories, partially offset by organic sales declines in the hand dish category.
Operating profit in Latin America decreased 1% in the third quarter of 2021 to $248, or 330 bps to 26.6% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (290 bps) and an increase in Selling, general and administrative expenses (10 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to significantly higher raw and packaging material costs (800 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (330 bps) and higher pricing. This increase in Selling, general and administrative expenses was due to higher overhead expenses (30 bps), driven by higher logistics costs, partially offset by decreased advertising investment (20 bps).
Europe

| Three Months Ended September 30,
| 2021 |  | 2020 |  | Change
Net sales | $ | 718 |  |  | $ | 712 |  |  | 1.0 |  | %
Operating profit | $ | 178 |  |  | $ | 169 |  |  | 5 |  | %
% of Net sales | 24.8 | % |  | 23.7 | % |  | 110 |  | bps

Net sales in Europe increased 1.0% in the third quarter of 2021 to $718 due to positive foreign exchange of 2.0%, partially offset by volume declines of 1.0% while net selling prices were flat. Organic sales in Europe decreased 1.0% in the third quarter of 2021. The organic sales declines were largely driven by the Filorga duty-free business and France, partially offset by organic sales growth in the United Kingdom and Germany.
The decrease in organic sales in Europe in the third quarter of 2021 versus the third quarter of 2020 was due to a decrease in Personal Care organic sales, partially offset by an increase in Oral Care organic sales. The decrease in Personal Care was primarily due to organic sales declines in the skin health, body wash and liquid hand soap categories. The increase in Oral Care was primarily due to organic sales growth in the toothpaste, prescription dental and manual toothbrush categories.
Operating profit in Europe increased 5% in the third quarter of 2021 to $178, or 110 bps to 24.8%, as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to a decrease in Selling, general and administrative expenses (190 bps), partially offset by a decrease in Gross profit (110 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (350 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (210 bps). This decrease in Selling, general and administrative expenses was due to decreased advertising investment (170 bps) and lower overhead expenses (20 bps).
35

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Asia Pacific

| Three Months Ended September 30,
| 2021 |  | 2020 |  | Change
Net sales | $ | 731 |  |  | $ | 722 |  |  | 1.0 |  | %
Operating profit | $ | 215 |  |  | $ | 222 |  |  | (3) |  | %
% of Net sales | 29.4 | % |  | 30.7 | % |  | (130) |  | bps

Net sales in Asia Pacific increased 1.0% in the third quarter of 2021 to $731 due to net selling price increases of 0.5% and positive foreign exchange of 1.5%, partially offset by volume declines of 1.0%. Organic sales in Asia Pacific decreased 0.5% in the third quarter of 2021. The organic sales declines were largely driven by the Greater China region and Australia, partially offset by organic sales growth in India.
The decrease in organic sales in Asia Pacific in the third quarter of 2021 versus the third quarter of 2020 was due to decreases in Personal Care and Home Care organic sales, partially offset by an increase in Oral Care organic sales. The decrease in Personal Care was primarily due to organic sales declines in the liquid hand soap and bar soap categories. The decrease in Home Care was primarily due to organic sales declines in the hand dish category. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and mouthwash categories, partially offset by organic sales declines in the manual toothbrush and power toothbrush categories.
Operating profit in Asia Pacific decreased 3% in the third quarter of 2021 to $215, or 130 bps to 29.4% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (130 bps), partially offset by an increase in Gross profit (20 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (240 bps), and higher pricing, partially offset by significantly higher raw and packaging material costs (300 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (110 bps), primarily driven by higher logistics costs and increased advertising investment (20 bps).
Africa/Eurasia

| Three Months Ended September 30,
| 2021 |  | 2020 |  | Change
Net sales | $ | 258 |  |  | $ | 255 |  |  | 1.0 |  | %
Operating profit | $ | 44 |  |  | $ | 61 |  |  | (28) |  | %
% of Net sales | 17.1 | % |  | 23.9 | % |  | (680) |  | bps

Net sales in Africa/Eurasia increased 1.0% in the third quarter of 2021 to $258 due to net selling price increases of 3.5% and positive foreign exchange of 2.0%, partially offset by volume declines of 4.5%. Organic sales in Africa/Eurasia decreased 1.0% in the third quarter of 2021. The organic sales declines were largely driven by the North Africa/Middle East region and South Africa, partially offset by organic sales growth in Turkiye and the Eurasia region.
The decrease in organic sales in Africa/Eurasia in the third quarter of 2021 versus the third quarter of 2020 was primarily due to a decrease in Personal Care organic sales, partially offset by an increase in Home Care organic sales. The decrease in Personal Care was primarily due to organic sales declines in the underarm protection category. The increase in Home Care was primarily due to organic sales growth in the fabric softener category.
Operating profit in Africa/Eurasia decreased 28% in the third quarter of 2021 to $44, or 680 bps to 17.1% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (380 bps) and a decrease in Gross profit (250 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to significantly higher raw and packaging material costs (670 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (240 bps) and higher pricing. This increase in Selling, general and administrative expenses was due to higher overhead expenses (480 bps), primarily driven by higher logistics costs, partially offset by decreased advertising investment (100 bps).
36

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Hill’s Pet Nutrition

| Three Months Ended September 30,
| 2021 |  | 2020 |  | Change
Net sales | $ | 845 |  |  | $ | 704 |  |  | 20.0 |  | %
Operating profit | $ | 233 |  |  | $ | 196 |  |  | 19 |  | %
% of Net sales | 27.6 | % |  | 27.8 | % |  | (20) |  | bps

Net sales for Hill’s Pet Nutrition increased 20.0% in the third quarter of 2021 to $845 due to volume growth of 11.0%, net selling price increases of 8.0% and positive foreign exchange of 1.0%. Organic sales in Hill’s Pet Nutrition increased 19.0% in the third quarter of 2021. Organic sales growth was led by the United States and Europe.
The increase in organic sales in the third quarter of 2021 was primarily due to organic sales growth in the Science Diet and Prescription Diet categories.
Operating profit in Hill’s Pet Nutrition increased 19% in the third quarter of 2021 to $233, while as a percentage of Net sales it decreased 20 bps to 27.6%. This decrease in Operating profit as a percentage of Net sales was due to an increase in Selling, general and administrative expenses (60 bps), partially offset by an increase in Gross profit (40 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to higher pricing and cost savings from the Company’s funding-the-growth initiatives (110 bps), partially offset by significantly higher raw and packaging material costs (300 bps). This increase in Selling, general and administrative expenses was due to increased advertising investment (120 bps), partially offset by lower overhead expense (60 bps).
Corporate

| Three Months Ended September 30,
| 2021 |  | 2020 |  | Change |
Operating profit (loss) | $ | (134) |  |  | $ | (122) |  |  | 10 |  | %

Operating profit (loss) related to Corporate was $(134) in the third quarter of 2021 as compared to $(122) in the third quarter of 2020. In the third quarter of 2020, Corporate Operating profit (loss) included benefits of $16 resulting from the Global Growth and Efficiency Program.
37

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Nine Months
Worldwide Net sales were $13,018 in the first nine months of 2021, up 7.0% as compared to the first nine months of 2020 due to volume growth of 1.5%, net selling price increases of 3.5% and positive foreign exchange of 2.0%. Organic sales increased 5.0% in the first nine months of 2021.
Net sales in the Oral, Personal and Home Care product segment were $10,592 in the first nine months of 2021, an increase of 5.5% as compared to the first nine months of 2020 due to net selling price increases of 3.0% and positive foreign exchange of 2.5%, while volume was flat. Organic sales in the Oral, Personal and Home Care product segment increased 3.0% in the first nine months of 2021.
The increase in organic sales in the first nine months of 2021 versus the first nine months of 2020 was due to an increase in Oral Care organic sales, partially offset by decreases in Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste, manual toothbrush and mouthwash categories. The decrease in Personal Care was primarily due to organic sales declines in the liquid hand soap and bar soap categories, partially offset by organic sales growth in the skin health category. The decrease in Home Care was primarily due to organic sales declines in the hand dish category, partially offset by organic sales growth in the fabric softener and liquid cleaner categories.
Net sales in the Hill’s Pet Nutrition segment were $2,426 in the first nine months of 2021, an increase of 16.0% from the first nine months of 2020 due to volume growth of 8.0%, net selling price increases of 5.5% and positive foreign exchange of 2.5%. Organic sales in the Hill’s Pet Nutrition segment increased 13.5% in the first nine months of 2021.
38

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Net Sales and Operating Profit by Segmen t
Net sales and Operating profit by segment were as follows:

| Nine Months ended September 30,
| 2021 |  | 2020
Net sales |  |  |
Oral, Personal and Home Care |  |  |
North America | $ | 2,765 |  |  | $ | 2,801 |
Latin America | 2,745 |  |  | 2,531 |
Europe | 2,144 |  |  | 2,004 |
Asia Pacific | 2,142 |  |  | 1,980 |
Africa/Eurasia | 796 |  |  | 736 |
Total Oral, Personal and Home Care | 10,592 |  |  | 10,052 |
Pet Nutrition | 2,426 |  |  | 2,095 |
Total Net sales | $ | 13,018 |  |  | $ | 12,147 |
Operating profit |  |  |
Oral, Personal and Home Care |  |  |
North America | $ | 585 |  |  | $ | 753 |
Latin America | 774 |  |  | 728 |
Europe | 524 |  |  | 482 |
Asia Pacific | 639 |  |  | 559 |
Africa/Eurasia | 153 |  |  | 174 |
Total Oral, Personal and Home Care | 2,675 |  |  | 2,696 |
Pet Nutrition | 661 |  |  | 588 |
Corporate | (369) |  |  | (368) |
Total Operating profit | $ | 2,967 |  |  | $ | 2,916 |

Within the Oral, Personal and Home Care product segment, North America Net sales decreased 1.5% as volume declines of 5.0% were partially offset by net selling price increases of 3.0% and positive foreign exchange of 0.5%. Organic sales in North America decreased 2.0%. Latin America Net sales increased 8.5% driven by volume growth of 2.0% and net selling price increases of 6.5% while foreign exchange was flat. Organic sales in Latin America increased 8.5%. Europe Net sales increased 7.0% driven by volume growth of 0.5% and positive foreign exchange of 6.5% while net selling prices were flat. Organic sales in Europe increased 0.5%. Asia Pacific Net sales increased 8.0% driven by volume growth of 4.0% and positive foreign exchange of 4.5%, partially offset by net selling price decreases of 0.5%. Organic sales in Asia Pacific increased 3.5%. Africa/Eurasia Net sales increased 8.0% driven by volume growth of 3.0% and net selling price increases of 5.0% while foreign exchange was flat. Organic sales in Africa/Eurasia increased 8.0%.
In the first nine months of 2021, Operating profit (loss) related to Corporate was $(369) as compared to $(368) in the first nine months of 2020. Corporate Operating profit (loss) for the nine months ended September 30, 2020 included acquisition-related costs of $6 and benefits of $16 resulting from the Global Growth and Efficiency Program.
39

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Gross Profit/Margin
Worldwide Gross profit increased to $7,816 in the first nine months of 2021 from $7,374 in the first nine months of 2020. Gross profit in the first nine months of 2020 included acquisition-related costs. Excluding acquisition-related costs in the first nine months of 2020, Gross profit increased to $7,816 in the first nine months of 2021 from $7,378 in the first nine months of 2020, reflecting an increase of $529 resulting from higher Net sales and a decrease of $91 resulting from lower Gross profit margin.
Worldwide Gross profit margin decreased to 60.0% in the first nine months of 2021 from 60.7% in the first nine months of 2020, due to higher raw and packaging material costs (400 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (200 bps) and higher pricing (120 bps).

|  | Nine Months ended September 30,
|  | 2021 |  | 2020
Gross profit, GAAP |  | $ | 7,816 |  |  | $ | 7,374 |
Acquisition-related costs |  | — |  |  | 4 |
Gross profit, non-GAAP |  | $ | 7,816 |  |  | $ | 7,378 |

|  | Nine Months ended September 30,
|  | 2021 |  | 2020 |  | Basis Point Change
Gross profit margin |  | 60.0 | % |  | 60.7 | % |  | (70) |

40

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased 10% to $4,809 in the first nine months of 2021 from $4,386 in the first nine months of 2020. Selling general and administrative expense in the first nine months of 2020 included benefits resulting from the Global Growth and Efficiency Program. Excluding the benefit resulting from the Global Growth and Efficiency Program in the first nine months of 2020, Selling, general and administrative expense increased to $4,809 in the first nine months of 2021 from $4,389 in the first nine months of 2020 reflecting higher overhead expenses of $287, driven by higher logistics costs, and increased advertising investment of $133.
Selling, general and administrative expenses as a percentage of Net sales increased to 36.9% in the first nine months of 2021 from 36.1% in the first nine months of 2020. This increase was due to higher overhead expenses (50 bps), driven by higher logistics costs (100 bps) which impacted all divisions, partially offset by other overhead efficiencies, and increased advertising investment (30 bps). In the first nine months of 2021, advertising investment increased as a percentage of Net sales to 11.8% from 11.5% in the first nine months of 2020, or 9.5% in absolute terms to $1,532, as compared with $1,399 in the first nine months of 2020.

|  | Nine Months ended September 30,
|  | 2021 |  | 2020
Selling, general and administrative expenses, GAAP |  | 4,809 |  |  | 4,386 |
Global Growth and Efficiency Program |  | — |  |  | 3 |
Selling, general and administrative expenses, non-GAAP |  | $ | 4,809 |  |  | $ | 4,389 |

|  | Nine Months ended September 30,
|  | 2021 |  | 2020 |  | Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales |  | 36.9 | % |  | 36.1 | % |  | 80

Other (Income) Expense, Net
Other (income) expense, net was $40 and $72 in the first nine months of 2021 and 2020, respectively. Excluding the benefit related to a value-added tax matter in Brazil in the first nine months of 2021 and benefits from the Global Growth and Efficiency Program and acquisition-related costs in the first nine months of 2020, Other (income) expense, net was $66 and $83 in the first nine months of 2021 and 2020, respectively.

|  | Nine Months ended September 30,
|  | 2021 |  | 2020
Other (income) expense, net, GAAP |  | $ | 40 |  |  | $ | 72 |
Value-added tax matter in Brazil |  | 26 |  |  | — |
Global Growth and Efficiency Program |  | — |  |  | 13 |
Acquisition-related costs |  | — |  |  | (2) |
Other (income) expense, net, non-GAAP |  | $ | 66 |  |  | $ | 83 |

41

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Operating Profit
Operating profit increased 2% to $2,967 in the first nine months of 2021 from $2,916 in the first nine months of 2020. Operating profit in the first nine months of 2021 included a benefit related to a value-added tax matter in Brazil. Operating profit in the first nine months of 2020 included acquisition-related costs and benefits from the Global Growth and Efficiency Program. Excluding these items in both periods as applicable, Operating profit increased to $2,941 in the first nine months of 2021 from $2,906 in the first nine months of 2020, primarily due to an increase in Gross profit, partially offset by an increase in Selling, general and administrative expenses.
Operating profit margin was 22.8% in the first nine months of 2021, a decrease of 120 bps compared to 24.0% in the first nine months of 2020. Excluding the items described above in both periods as applicable, Operating profit margin was 22.6% in the first nine months of 2021, a decrease of 130 bps compared to 23.9% in the first nine months of 2020, primarily due to an increase in Selling, general and administrative expenses (80 bps) and a decrease in Gross profit (70 bps), both as a percentage of Net sales.

|  | Nine Months ended September 30,
|  | 2021 |  | 2020 |  | % Change
Operating profit, GAAP |  | $ | 2,967 |  |  | $ | 2,916 |  |  | 2 | %
Value-added tax matter in Brazil |  | (26) |  |  | — |  |  |
Global Growth and Efficiency Program |  | — |  |  | (16) |  |  |
Acquisition-related costs |  | — |  |  | 6 |  |  |
Operating profit, non-GAAP |  | $ | 2,941 |  |  | $ | 2,906 |  |  | 1 | %

|  | Nine Months ended September 30,
|  | 2021 |  | 2020 |  | Basis Point Change
Operating profit margin, GAAP |  | 22.8 | % |  | 24.0 | % |  | (120) |
Value-added tax matter in Brazil |  | (0.2) |  |  | — |  |  |
Global Growth and Efficiency Program |  | — |  |  | (0.1) |  |  |
Acquisition-related costs |  | — |  |  | — |  |  |
Operating profit margin, non-GAAP |  | 22.6 | % |  | 23.9 | % |  | (130) |

Non-Service Related Postretirement Costs
Non-service related postretirement costs were $52 in the first nine months of 2021 as compared to $56 in the first nine months of 2020.
42

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Interest (Income) Expense, Net
Interest (income) expense, net was $152 in the first nine months of 2021 as compared to $107 in the first nine months of 2020. The increase in Interest (income) expense, net in the first nine months of 2021 as compared to the first nine months of 2020, was primarily due to the loss on the early extinguishment of debt during the third quarter of 2021 of $75, representing the difference between the redemption price of the Canada notes and the carrying amount of the debt extinguished. Excluding the loss on the early extinguishment of debt, Interest (income) expense, net was $77 in the first nine months of 2021 as compared to $107 in the first nine months of 2020, primarily due to lower average interest rates on debt.

|  | Nine Months Ended September 30,
|  | 2021 |  | 2020
Interest (income) expense, net, GAAP |  | $ | 152 |  |  | $ | 107 |
Loss on early extinguishment of debt |  | (75) |  |  | — |
Interest (income) expense, net, non-GAAP |  | $ | 77 |  |  | $ | 107 |

43

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Income Taxes
The effective income tax rate was 20.2% for the third quarter of 2021 as compared to 23.0% for the third quarter of 2020. As reflected in the table below, the non-GAAP effective income tax rate was 20.7% for the third quarter of 2021, as compared to 23.0% in the comparable period of 2020.
The effective income tax rate was 22.2% for the first nine months of 2021 as compared to 21.2% for the first nine months of 2020. As reflected in the table below, the non-GAAP effective income tax rate was 22.3% for the first nine months of 2021, as compared to 23.9% in the comparable period of 2020.
The quarterly provision for income taxes is determined based on the Company’s estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 22.6%, compared to 24.0% in the third quarter of 2020. See Note 10, Income Taxes to the Condensed Consolidated Financial Statements for additional details.

|  | Three Months Ended September 30,
|  | 2021 |  | 2020
|  | Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Effective Income Tax Rate(2) |  | Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Effective Income Tax Rate(2)
As Reported GAAP |  | $ | 853 |  |  | $ | 172 |  |  | 20.2 | % |  | $ | 967 |  |  | $ | 222 |  |  | 23.0 | %
Loss on early extinguishment of debt |  | 75 |  |  | 20 |  |  | 0.5 | % |  | — |  |  | — |  |  | — |
Global Growth and Efficiency Program |  | — |  |  | — |  |  | — |  |  | (16) |  |  | (3) |  |  | — |
Non-GAAP |  | $ | 928 |  |  | $ | 192 |  |  | 20.7 | % |  | $ | 951 |  |  | $ | 219 |  |  | 23.0 | %

|  | Nine Months ended September 30,
|  | 2021 |  | 2020
|  | Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Effective Income Tax Rate(2) |  | Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Effective Income Tax Rate(2)
As Reported GAAP |  | $ | 2,763 |  |  | $ | 613 |  |  | 22.2 | % |  | $ | 2,753 |  |  | $ | 585 |  |  | 21.2 | %
Value-added tax matter in Brazil |  | (26) |  |  | (6) |  |  | — |  |  | — |  |  | — |  |  | — |
Loss on early extinguishment of debt |  | 75 |  |  | 20 |  |  | 0.1 | % |  | — |  |  | — |  |  | — |
Global Growth and Efficiency Program |  | — |  |  | — |  |  | — |  |  | (16) |  |  | (3) |  |  | — |
Subsidiary and operating structure initiatives |  | — |  |  | — |  |  | — |  |  | — |  |  | 71 |  |  | 2.7 | %
Acquisition-related costs |  | — |  |  | — |  |  | — |  |  | 6 |  |  | 2 |  |  | — |
Non-GAAP |  | $ | 2,812 |  |  | $ | 627 |  |  | 22.3 | % |  | 2,743 |  |  | 655 |  |  | 23.9 | %

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
The provision for income taxes for the nine months ended September 30, 2020 includes $71 of income tax benefits recorded on a discrete period basis, of which $45 relates to previously recorded foreign withholding taxes and $26 relates to a previously recorded valuation allowance against a deferred tax asset. As more fully described below, both items were previously recorded in connection with the charge recorded by the Company in 2017 and revised in 2018 related to the TCJA.
44

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
As part of the previously recorded charge for the TCJA, the Company had provided for foreign withholding taxes expected to be paid on the remittance of earnings from certain overseas subsidiaries no longer deemed indefinitely reinvested. As a result of a reorganization of the ownership structure of certain foreign subsidiaries, the Company determined that no withholding taxes will be due on the remittance by certain subsidiaries of earnings previously deemed reinvested and, accordingly, reversed $45 of previously recorded foreign withholding taxes in the first quarter of 2020.
Also as part of the previously recorded charge for the TCJA, the Company provided a valuation allowance against a deferred tax asset related to foreign tax credit carry-forwards that the Company did not expect to be able to use due to changes made by the TCJA. As a result of a new operating structure implemented within one of the Company’s divisions, the Company believes the use of these foreign tax credit carry-forwards will not be limited in the future and, accordingly, in the first quarter of 2020 reversed the previously recorded valuation allowance of $26.
45

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share
Net income attributable to Colgate-Palmolive Company in the first nine months of 2021 decreased to $2,018 from $2,048 in the comparable 2020 period. Earnings per common share on a diluted basis was $2.38 in the first nine months of 2021 and 2020. Net income attributable to Colgate-Palmolive Company in the first nine months of 2021 included a benefit related to a value-added tax matter in Brazil and a loss on the early extinguishment of debt. Net income attributable to Colgate-Palmolive Company in the comparable 2020 period included benefits resulting from Global Growth and Efficiency Program, acquisition-related costs and a benefit related to subsidiary and operating structure initiatives.
Excluding the items described above in both periods as applicable, Net income attributable to Colgate-Palmolive Company in the first nine months of 2021 increased 4% to $2,053 from $1,968 in the first nine months of 2020, and Earnings per common share on a diluted basis increased 6% to $2.42 in the first nine months of 2021 from $2.29 in the first nine months of 2020.

| Nine Months Ended September 30, 2021
| Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Net Income Including Noncontrolling Interests |  | Net Income Attributable To Colgate-Palmolive Company |  |  |  | Diluted Earnings Per Share(2)
As Reported GAAP | $ | 2,763 |  |  | $ | 613 |  |  | $ | 2,150 |  |  | $ | 2,018 |  |  |  |  | $ | 2.38 |
Value-added tax matter in Brazil | (26) |  |  | (6) |  |  | (20) |  |  | (20) |  |  |  |  | (0.02) |
Loss on early extinguishment of debt | 75 |  |  | 20 |  |  | 55 |  |  | 55 |  |  |  |  | 0.06 |
Non-GAAP | $ | 2,812 |  |  | $ | 627 |  |  | $ | 2,185 |  |  | $ | 2,053 |  |  |  |  | $ | 2.42 |

| Nine Months Ended September 30, 2020
| Income Before Income Taxes |  | Provision For Income Taxes(1) |  | Net Income Including Noncontrolling Interests |  |  | Net Income Attributable To Colgate-Palmolive Company |  |  | Diluted Earnings Per Share(2)
As Reported GAAP | $ | 2,753 |  |  | $ | 585 |  |  | $ | 2,168 |  |  |  | $ | 2,048 |  |  |  | $ | 2.38 |
Global Growth and Efficiency Program | (16) |  |  | (3) |  |  | (13) |  |  |  | (13) |  |  |  | (0.02) |
Subsidiary and operating structure initiatives | — |  |  | 71 |  |  | (71) |  |  |  | (71) |  |  |  | (0.08) |
Acquisition-related costs | 6 |  |  | 2 |  |  | 4 |  |  |  | 4 |  |  |  | 0.01 |
Non-GAAP | $ | 2,743 |  |  | $ | 655 |  |  | $ | 2,088 |  |  |  | $ | 1,968 |  |  |  | $ | 2.29 |

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
46

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Non-GAAP Financial Measures
This Quarterly Report on Form 10-Q discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Quarterly Report on Form 10-Q. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments, as applicable. A reconciliation of organic sales growth to Net sales growth for the three and nine months ended September 30, 2021 is provided below.
Worldwide Gross profit, Gross profit margin, Other (income) expense, net, Operating profit, Operating profit margin, effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and excluding, as applicable, a value-added tax matter in Brazil, benefits resulting from the Global Growth and Efficiency Program, a loss on the early extinguishment of debt, acquisition-related costs and a benefit related to a reorganization of the ownership structure of certain foreign subsidiaries and a new operating structure implemented within one of the Company’s divisions. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain acquisitions, divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three and nine months ended September 30, 2021 and 2020 is presented within the applicable section of Results of Operations.
The following tables provide a quantitative reconciliation of Net sales growth to organic sales growth for the three and nine months ended September 30, 2021:

Three Months Ended September 30, 2021 | Net Sales Growth (GAAP) | Foreign Exchange Impact | Acquisitions and Divestments Impact | Organic Sales Growth (Non-GAAP)
Oral, Personal and Home Care |  |  |  |
North America | 1.0% | 0.5% | —% | 0.5%
Latin America | 11.0% | 3.0% | —% | 8.0%
Europe | 1.0% | 2.0% | —% | (1.0)%
Asia Pacific | 1.0% | 1.5% | —% | (0.5)%
Africa/Eurasia | 1.0% | 2.0% | —% | (1.0)%
Total Oral, Personal and Home Care | 3.5% | 2.0% | —% | 1.5%
Pet Nutrition | 20.0% | 1.0% | —% | 19.0%
Total Company | 6.5% | 2.0% | —% | 4.5%

47

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)

Nine Months Ended September 30, 2021 | Net Sales Growth (GAAP) | Foreign Exchange Impact | Acquisitions and Divestments Impact | Organic Sales Growth (Non-GAAP)
Oral, Personal and Home Care |  |  |  |
North America | (1.5)% | 0.5% | —% | (2.0)%
Latin America | 8.5% | —% | —% | 8.5%
Europe | 7.0% | 6.5% | —% | 0.5%
Asia Pacific | 8.0% | 4.5% | —% | 3.5%
Africa/Eurasia | 8.0% | —% | —% | 8.0%
Total Oral, Personal and Home Care | 5.5% | 2.5% | —% | 3.0%
Pet Nutrition | 16.0% | 2.5% | —% | 13.5%
Total Company | 7.0% | 2.0% | —% | 5.0%

48

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Liquidity and Capital Resources
The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, share repurchases and acquisitions). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.
Net cash provided by operations decreased 19% to $2,219 in the first nine months of 2021, compared with $2,756 in the comparable period of 2020, primarily due to higher working capital and higher taxes paid. The Company continues to be tightly focused on working capital. The Company’s working capital was (3.8%) as a percentage of Net sales as of September 30, 2021 as compared to (5.7%) as of September 30, 2020. The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt).
Investing activities used $462 of cash in the first nine months of 2021, compared with $668 in the comparable period of 2020. Investing activities in the first nine months of 2020 included the Company’s acquisition of hello for cash consideration of $351. This acquisition was financed with a combination of debt and cash.
Capital spending was $374 in the first nine months of 2021 compared to $249 in the comparable period of 2020. Capital expenditures for 2021 are expected to be approximately 3.0% to 3.5% of Net sales. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns.
Financing activities used $1,668 of cash during the first nine months of 2021, compared with $1,968 used in the comparable period of 2020. This primarily reflects a net increase in commercial paper borrowing in the first nine months of 2021 compared with the comparable period of 2020. This source of cash was partially offset by higher share repurchases associated with the share repurchase program, lower proceeds from the exercise of stock options and higher principal payments on debt in the first nine months of 2021 compared with the comparable period of 2020. As previously disclosed, during the year ended December 31, 2020, the Company moderated its share repurchases, net of proceeds from the exercise of stock options, to reduce incremental debt levels related to acquisitions. During the first nine months of 2021, the Company’s share repurchases, net returned to historical levels.
Long-term debt, including the current portion, increased to $7,693 as of September 30, 2021, as compared to $7,343 as of December 31, 2020, and total debt was $7,696 as of September 30, 2021, as compared to $7,601 as of December 31, 2020. The Company’s debt issuances support the Company’s capital structure objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital.
In 1990, CP Canada, issued C$145 of Canadian dollar-denominated unsecured unsubordinated 12.85% guaranteed notes due October 4, 2030. On August 26, 2021, CP Canada redeemed the Canada notes and recorded a loss on the early extinguishment of debt of $75 pretax ($55 aftertax), which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished.
Domestic and foreign commercial paper outstanding was $1,633 and $91 as of September 30, 2021 and 2020, respectively. The average daily balances outstanding for commercial paper in the first nine months of 2021 and 2020 were $2,061 and $1,110, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its unused lines of credit (including under the facilities discussed below) or by issuing long-term debt pursuant to an effective shelf registration statement. In August 2021, the Company entered into a new $3,000 five-year revolving credit facility with a syndicate of banks for a five-year term expiring August 2026, which replaced, on substantially similar terms, the Company's $2,650 revolving credit facility that was scheduled to expire in November 2024. Commitment fees related to the credit facility are not material. The Company's $1,500 364-day credit facility with a syndicate of banks expired in August 2021 and was not renewed.
49

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote. Refer to Note 6, Long Term Debt and Credit Facilities to the Consolidated Financial Statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 for further information about the Company’s long-term debt and credit facilities.
In the first quarter of 2021, the Company increased the quarterly common stock dividend to $0.45 per share from $0.44 per share previously, effective in the second quarter of 2021.
Cash and cash equivalents increased $70 during the first nine months of 2021 to $958 at September 30, 2021, compared to $888 at December 31, 2020, the majority of which ($897 and $832, respectively) was held by the Company’s foreign subsidiaries.
During the nine months ended September 30, 2021, COVID-19 did not have a significant impact on the Company’s liquidity for its continued operating and cash needs. For more information regarding the impact of COVID-19, see “Executive Overview” above and “Risk Factors” in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.
For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.
50

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Goodwill and Indefinite-Lived Intangible Assets
Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate an asset may be impaired. In assessing impairment, the Company performs either a quantitative or a qualitative analysis.
As previously disclosed, as of the date of the annual goodwill impairment test, for the recently acquired Filorga business, where there is inherently a lower surplus of fair value over carrying value, the estimated fair value of the Filorga reporting unit exceeded its carrying value by less than 5%. Either a reduction in the long-term growth rate of 25 basis points or an increase in the discount rate of 25 basis points would result in the fair value of the Filorga reporting unit approximating its carrying value.
While management remains confident about the long-term potential of Filorga, given the inherent uncertainties in estimating the future impacts of the COVID-19 pandemic on global macroeconomic conditions and interest rates in general and on the Filorga business in particular, actual results may differ from management’s current estimates and could have an adverse impact on one or more of the assumptions used in our quantitative model related to the Filorga reporting unit resulting in potential impairment charges in subsequent periods. Given the recent acquisition of Filorga, management will continue to assess triggering events that may necessitate additional qualitative or quantitative analyses in future periods.
51

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In certain limited circumstances, the COVID-19 pandemic has impacted the ability of our third-party vendors to provide the Company with reliable updated market share data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.
Cautionary Statement on Forward-Looking Statements
This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange volatility, the impact of COVID-19, cost-reduction plans, tax rates, new product introductions, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic and political environment in different countries and its effect on consumer spending habits, foreign currency rate fluctuations, exchange controls, tariffs, price or profit controls, labor relations, changes in foreign or domestic laws, or regulations or their interpretation, political and fiscal developments, including changes in trade, tax and immigration policies, increased competition and evolving competitive practices (including from the growth of eCommerce and the entry of new competitors and business models), the ability to operate and respond effectively during a pandemic, epidemic or widespread public health concern, including COVID-19, ability to manage disruptions in our global supply chain and/or key office facilities, ability to manage the availability and cost of raw and packaging materials and logistics costs, the ability to maintain or increase selling prices as needed, changes in the policies of retail trade customers, the emergence of alternative retail channels, the growth of eCommerce and the rapidly changing retail landscape (as consumers increasingly shop online), the ability to develop innovative new products, the ability to continue lowering costs and operate in an agile manner, the ability to maintain the security of our information technology systems from a cyber-security incident or data breach, the ability to address the effects of climate change and achieve our sustainability and social impact goals, the ability to complete acquisitions and divestitures as planned, the ability to successfully integrate acquired businesses, the ability to attract and retain key employees and integrate diversity, equity and inclusion initiatives across our organization, the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit, and the ability to address uncertain or unfavorable global economic conditions, disruptions in the credit markets and tax matters. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent Quarterly Reports on Form 10-Q).
52

COLGATE-PALMOLIVE COMPANY
Management’s Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)
Quantitative and Qualitative Disclosures about Market Risk
There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the year ended December 31, 2020.
53

COLGATE-PALMOLIVE COMPANY
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of September 30, 2021 (the “Evaluation”). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.
Changes in Internal Control Over Financial Reporting
The Company is in the process of upgrading its enterprise IT system to SAP S/4 HANA. This change has not had and is not expected to have a material impact on the Company’s internal control over financial reporting.
Except as noted above, there were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
54

COLGATE-PALMOLIVE COMPANY
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
For information regarding legal matters, please refer to Note 11, Contingencies to the Condensed Consolidated Financial Statements contained in Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.
Item 1A. Risk Factors
There have been no material changes from the risk factors disclosed in Part 1, Item 1A. Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.
55

COLGATE-PALMOLIVE COMPANY
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.
The following table shows the stock repurchase activity for the three months ended September 30, 2021:

Month |  | Total Number of Shares Purchased(1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
July 1 through 31, 2021 |  | 731,516 |  |  | $ | 82.62 |  |  | 705,454 |  |  | $ | 1,071 |
August 1 through 31, 2021 |  | 1,305,856 |  |  | $ | 78.56 |  |  | 1,304,000 |  |  | $ | 968 |
September 1 through 30, 2021 |  | 1,032,307 |  |  | $ | 76.93 |  |  | 984,150 |  |  | $ | 892 |
Total |  | 3,069,679 |  |  | $ | 78.98 |  |  | 2,993,604 |  |  |

(1) Includes share repurchases under the 2018 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.
(2) The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 76,075 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.
(3) Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of September 30, 2021.
56

COLGATE-PALMOLIVE COMPANY
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable.
Item 5. Other Information
The Company currently maintains the Colgate-Palmolive Company Above and Beyond Plan (the “A&B Plan”) for the benefit of eligible executives of the Company and its designated subsidiaries. On October 28, 2021, the Company’s Board of Directors terminated the A&B Plan, effective as of June 30, 2022, and discontinued the following components of the A&B Plan prior to the termination date: (1) no new cash allowances shall be provided to any eligible executive for years after December 31, 2021; (2) enhanced long-term disability coverage shall be discontinued effective as of December 31, 2021; and (3) no eligible executive who dies after December 31, 2021 shall be eligible for the death in service benefit.
57

COLGATE-PALMOLIVE COMPANY
Item 6. Exhibits

Exhibit No. |  | Description
10-A |  | Five Year Credit Agreement, dated as of August 20, 2021, by and among Colgate-Palmolive Company, as Borrower, Citibank, N.A., as Administrative Agent and Arranger, and the Lenders party thereto.**
10-B |  | Colgate-Palmolive Company Deferred Compensation Plan, amended and restated, effective as of October 28, 2021.* **
31-A |  | Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.**
31-B |  | Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.**
32 |  | Certificate of the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350.***
101 |  | The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2021, formatted in Inline eXtensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; (v) Condensed Consolidated Statements of Changes in Shareholders’ Equity; and (vi) Notes to Condensed Consolidated Financial Statements.
104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

__________
* Indicates a management contract or compensatory plan or arrangement.
** Filed herewith.
*** Furnished herewith.
58

COLGATE-PALMOLIVE COMPANY
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| COLGATE-PALMOLIVE COMPANY
| (Registrant)
| Principal Executive Officer:
October 29, 2021 | /s/ Noel R. Wallace
| Noel R. Wallace
| Chairman of the Board, President and Chief Executive Officer
| Principal Financial Officer:
October 29, 2021 | /s/ Stanley J. Sutula III
| Stanley J. Sutula III
| Chief Financial Officer
| Principal Accounting Officer:
October 29, 2021 | /s/ Philip G. Shotts
| Philip G. Shotts
| Vice President and Controller

59